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COMMENTS
A CASE FOR FEDERAL FUNDING OF
HUMAN EMBRYONIC STEM CELL
RESEARCH: THE INTERPLA Y OF MORAL
ABSOLUTISM AND SCIENTIFIC RESEARCH
Robert E. McGough*
INTRODUCTION
Great leaps in science traditionally precipitate consternation among
moral, ethical and legal thinkers. It is the collective conscience of
mankind that demands an investigation into the repercussions of
humankind's rapidly developing power over nature. Today, this
phenomenon is perhaps best illustrated by swift advancements within the
field of biotechnology. Rapid progress during the last few decades in
biotechnology-specifically alternative reproductive technologies (ART)
such as in vitro fertilization (IVF) and human embryology-has
consistently outpaced critical thinking by ethicists, theologians and
lawmakers with regard to the effect that progress has on humanity.1
Critical thinking on the issue is embodied in the burgeoning field of
bioethics, which has been aptly characterized as "a discipline, language,
and political movement."2 The relationship between biotechnological
* J.D. 2001, The Catholic University of America, Columbus School of Law.
Associate, Morgan, Lewis & Bockius LLP. The author would like to thank
Professor George P. Smith for his comments, advice and support in preparing this
article.
1. See George P. Smith, II, Pathways to Immortality in The New Millennium:
Human Responsibility, Theological Direction, or Legal Mandate, 15 ST. Louis U.
PUB. L. REV. 447 (1996). See also Davor Solter, Cloning and Embryonic Stem
Cells: a New Era in Human Biology and Medicine, 40 CROATIAN MED. J. 1 (Mar.
1999), available at http://www.mefst.hr/cmj/1999/4003/400301.htm.
2. George P. Smith, II, Judicial Decisionmaking in the Age of Biotechnology,
13 NOTRE DAME J.L. ETHICS & PUB. POL'Y 93 (1999).
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advancement and bioethical evaluation of that advancement is best
described as reactionary. New possibilities generated by scientific
research-both good and bad-must be evaluated as they are disclosed.
Perhaps the most appropriate analogy to be applied to this relationship's
dichotomy of thought is Sir Isaac Newton's third law of physics, which
demands that for each and every action there is an equal and opposite
reaction: "For every new and daring biotechnological advancement.., a
challenge rooted in complex social, religious, moral and ethical vectors of
force" is presented.' In the field of cellular biology, such an advancement
was reported in November of 1998.4
Developmental biologist Dr. James Thomson and his colleagues at the
University of Wisconsin reported in Science magazine their ability to
successfully culture and sustain stem cells extracted from a human embryo
in the laboratory.5 Their achievement constitutes no less than a
revolutionary breakthrough for medical science-the potential benefit to
human health that could be realized through research utilizing these cells
6is currently unlimited.
Stem cells are unspecialized cells that give rise to specialized cells. 7 As
discussed in more detail in Section I below, human embryonic stem cells
are "pluripotent," which means they have the potential to develop into
virtually any tissue type. The isolation and sustained culture of human
embryonic stem cells gives hope to hundreds of millions worldwide who
3. Smith, Judicial Decisionmaking, supra note 2, at 94 (citation omitted).
4. See James A. Thomson et al., Embryonic Stem Cell Lines Derived from
Human Blastocytes, SCIENCE, Nov. 6, 1998, at 282.
5. See id.; see also Gwen Carleton, UW Reports Cell Breakthrough; Work
Could Revolutionize Transplants, CAPITOL TIMES (Madison, Wis.), Nov. 5, 1998, at
1A.
6. Carleton, supra note 5, at IA; First Derivation of Human Embryonic Stem
Cells Reported in Science; Geron Holds Worldwide License to Breakthrough
Discovery with Promise for Treating Degenerative Diseases, Bus. WIRE, Nov. 5,
1998; James Walker & Timothy Johnson, Enormous Scientific Breakthrough
(ABC television broadcast, Nov. 5, 1998); Scientists Find Way to Reproduce
Embryonic Stem Cells Which Could Eventually Help to Cure All Diseases, (NBC
television broadcast, Nov. 5, 1998); Human Stem Cell Breakthrough Heralds New
Era of 'Gero-Technology,' PR NEWSWIRE, Nov. 5, 1998.
7. THE AMERICAN HERITAGE DICrIONARY 1193 (2d ed. 1991).
8. Audrey S. Chapman et al., Stem Cell Research-Monitoring the Frontiers
of Biomedical Research, AM. ASS'N FOR THE ADVANCEMENT OF SCI. & INST. FOR
CIVIL Soc'Y, Nov. 1999, at 1 [hereinafter AAAS REPORT].
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suffer from a myriad of degenerative ailments.9 So, why the controversy?
The answer is simple. The best sources of the most promising stem cells10
related to this research are excess cryogenically frozen human embryos
from IVF treatments (i.e., embryos that could develop into a full human
being if thawed and implanted into a woman's uterus).,1  As discussed
further in section I.A. below, there are between 30,000 to 150,000 frozen
embryos left over from IVF treatments in the United States alone." If not
used for research purposes, these frozen embryos would likely be
destroyed. 3
A ban on federal funding of scientific research that involves either
creating, discarding, destroying or otherwise subjecting human embryos to
risk of injury or death for research purposes has been in effect since
1996.14 The ban was the result of a budget compromise between
Republicans and Democrats during the government shut down crisis of
early 1996.15 Aider a series of promising reports on the potential benefits
of embryonic stem cell research and a reinterpretation by the Department
of Health and Human Services (HHS) of the 1996 Act, the Clinton
Administration and the National Institutes of Health (NIH) concluded in
1999 that embryonic stem cell research could be federally funded.
6
However, the issue of federal funding for embryonic stem cell research
was revisited and indefinitely delayed by the Bush Administration a short
9. Shunping Wang & John D. Gearhart, Human Pluripotent Stem Cells,
NEoREVIEWS, July 2000, at e32; Daniel Perry, Patients' Voices: The Powerful
Sound in the Stem Cell Debate, 287 Sci. 1423, Feb. 25, 2000. Data collected by the
Patients' Coalition for Urgent Research indicates that human pluripotent stem
cell research has the potential to help hundreds of millions of people worldwide
(including 128.4 million Americans) suffering from cardiovascular diseases,
autoimmune diseases, diabetes, osteoporosis, cancer, Alzheimer's disease,
Parkinson's disease, severe burns, spinal cord injuries and birth defects. Id.
10. See infra Section I.
11. Id.
12. See Terry Eastland, We Must Stop the Eugenics Revolution, DALLAS
MORNING NEWS, July 31, 2001, at 17A.
13. See Science and Credibility, Editorial, ST. Louis POST-DISPATCH, Sept. 9,
2001, at B2; Lynne Langley, Stem Cell Research Not Restricted to Embryos, POST
AND COURIER (Charleston, S.C.), Aug. 20, 2001, at Al.
14. See infra note 117.
15. See infra Section II.B.
16. See infra Section II.C.
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17
time after President Bush took office in January 2001. Ultimately, as
discussed in greater detail in section II.E. below, the Bush Administration
decided to allow federal funding for research on a limited number of stem
cell lines already created, but not for research that implicates the further
18destruction of human embryos.
The debate regarding the ethical implications of using federal funds to
sponsor such research has been raging since Dr. Thomson's
announcement in November 1998.'9 Although the moral, ethical and legal
issues enmeshed with IVF technologies and embryo research had been
previously considered, the real debate began in November 1998, when it
became evident to the Clinton Administration that the vast benefits of
human pluripotent stem cell research would more likely be realized with
an infusion of federal funding." While numerous scientists, patient
advocacy groups, bioethicists and others hailed the courage of HHS's and
NIH's interpretation of the embryo research ban, others decried their
actions as tantamount to murder." Moreover, so-called "pro-life" groups
have recently become emboldened in their opposition to federal funding
for embryonic stem cell research through the election of George W. Bush,
Jr. as the nation's fourty-third President. President Bush, a Republican
and self-described supporter of the pro-life movement, indicated during
his campaign that his administration would oppose providing further
22
federal funding for fetal tissue research . However, his statements on
17. Rick Weiss, Bush Administration Order Halts Stem Cell Meeting; NIH.
Planned Session to Review Fund Requests, WASH. POST, Apr. 21, 2001, at A2.
18. See President George W. Bush, National Address (Aug. 9, 2001), in
WASH. POST, Aug. 10, 2001, at A12 [hereinafter National Address].
19. The origination of the debate actually precedes Thomson's
announcement. However, for purposes of this Comment, it will be assumed that
the debate involving the ethics of human pluripotent stem cell research did not
mature until it was evident (through Thomson's work) that isolating and culturing
human pluripotent stem cells from embryos was possible.
20. See infra Section II.C.
21. See, e.g., Aaron Zitner, NIH Identifies Stem Cell Sets Ok'd for Funds, L.A.
TIMES, Aug. 28, 2001, at Al; American Bioethics Advisory Commission to Blast
NIH for Human Tissue Laundering Scheme, PR NEWSWIRE, Jan. 22, 1999
(quoting American Bioethics Advisory Commission Director Fr. Joseph Howard,
Washington Dateline Section, "The fact is these [stem] cells have an origin, and in
this case the origin is murdered babies.") (on file with author).
22. See, e.g., Arthur Allen, Will Thompson, Bush Clash Over Human Embryo
Research?, Salon.com, (Dec. 29, 2000), at
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federal funding for embryonic stem cell research, as discussed below in
Section II.E., had been somewhat vague until August 9, 2001, when
President Bush stated in a nationally-televised address that his
administration would support limited federal funding for research on
embryos that had already been destroyed. 3
Therein lies the dilemma. Is the use of excess frozen embryos for stem
cell research, which necessarily implicates their destruction, ethically,
morally and legally acceptable? Given the divergence of viewpoints on
the issue, it is imperative to balance the benefits of the research against
the perceived harms.24 According to George P. Smith, a bioethicist and
professor at Columbus School of Law, the "penultimate goal" when
balancing the necessity, priorities and values of such a decision is "the
formulation and validation of a final action which minimizes human
suffering and maximizes the social good., 25 After carefully balancing the
potential medical benefits and the moral, ethical and legal issues involved,
it is clear that the decision to provide federal funding for human
pluripotent stem cell research should be upheld, and perhaps even
extended. While the legalistic approach taken by the Clinton
Administration in navigating around the federal ban on embryonic
research is open to criticism (and justly so), federal funding of this
research is not only legally, ethically and morally acceptable, it is of
paramount importance to humanity.
This Comment is divided into four sections. Section I provides a
scientific backdrop of human stem cell research. Section II analyzes the
history of the Federal Government's involvement in embryonic stem cell
research. Section III examines the moral, ethical and legal implications at
issue. In Section IV, after a careful consideration and balancing of all the
factors involved, this Comment concludes that one must not sacrifice such
great potential for the relief of human suffering based on absolutist views
or politically expedient positions. Rather, we, as a society, must make the
choice to fully fund this blossoming science so that we may all live better,
healthier lives.
http://www.salon.com/politics/feature/2000/ 12/29/embryo/index.htmi (quoting
Bush spokesperson, Scott McClellan, "Bush has 'consistently opposed federal
funding for research that requires embryos to be discarded or destroyed."').
23. See supra note 1&
24. Smith, supra note 2, at 95.
25. Id. at 94.
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I. THE SCIENCE OF STEM CELL RESEARCH
Science by itself has no moral dimension. But it does seek to establish
truth. And upon this truth morality can be built.26
Stem cell research is not a new discipline. Knowledge of the potential
application of stem cell science has accumulated since the early 1970s,
when bona fide stem cells were identified in mice. In fact, some stem
cell therapies are already being utilized. 2' However, it was not until 1998,
with the success of Dr. James Thomson and his colleagues at the
University of Wisconsin, that the possibility of manipulating stem cells to
grow specific human tissues toward treating dozens (if not more) of• 29
degenerative conditions became a reality.
In order to draw any ethical, moral or legal conclusions regarding the
use of human embryonic stem cells for research purposes, it is necessary
to understand the science of stem cells, particularly the sources and
characteristics of different types of stem cells as well as their varying
applications. In addition, before proceeding to the discussion of the
different types of stem cells and their various characteristics and
applications, it is appropriate to provide some background on both in
vitro fertilization and cryopreservation, two procedures that are of central
importance in the science discussed in this Comment. The IVF technique
was originally developed to artificially impregnate women who suffered
from fallopian tube defects. 0  Put simply, IVF involves hormonal
stimulation a woman's ovaries to prematurely ripen as many eggs as
possible, collection of those eggs upon maturity, and fertilization in vitro31
26. JAMES B. SIMPSON, SIMPSON'S CONTEMPORARY QUOTATIONS (1988),
available at http://www.bartleby.com/63/85/3185.html (quoting William H.
Masters, Life Magazine, June 24, 1966).
27. AAAS REPORT, supra note 8, at 1.
28. See id. The most well-known of these therapies is a form of bone marrow
transplant in which patients are infused with stem cells extracted from bone
marrow in order to restore tissue destroyed by chemotherapy or radiation
therapy. See id. at 1-2.
29. See id.
30. Lynne M. Thomas, Comment, Abandoned Frozen Embryos and Texas
Law of Abandoned Personal Property: Should There Be a Connection?, 29 ST.
MARY'S L.J. 255, 265 (1997).
31. Translated from Latin, in vitro means literally "in glass." The American
Heritage Dictionary defines in vitro as "In an artificial environment outside the
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in a laboratory using collected sperm from a donor (usually the
husband).32 The fertilized eggs are then permitted to develop in vitro for a
period of time before they are implanted in the woman's uterus. Before
the fertilized eggs are implanted, however, physicians must decide how
many of them to implant. Implantation of three to four fertilized eggs
(embryos) is relatively common.33 If there are remaining embryos after
implantation, the parents, as "owners," have the responsibility to decide
whether they are donated, destroyed or frozen cryogenically for future
34
use.
Cryopreservation techniques were developed subsequent to IVF.33
Through work pioneered by English and Australian scientists, it became
possible to add a protective agent to embryos that insulates them from the
36hazards of being frozen in liquid nitrogen. Once frozen, the embryos can
31be thawed and implanted to induce a successful pregnancy.
The first successful IVF pregnancy in the United States occurred in
1981.38 The first successful birth of a cryogenically frozen embryo in the
United States was reported in 1985. 3' However, data indicates that the
success rate attributed to the implantation of cryopreserved embryos lags
behind that of embryos that have not been frozen.4
A. Sources and Characteristics of Stem Cells
There are three types of stem cells: (1) human embryonic stem cells
(ES cells); (2) human embryonic germ cells (EG cells); and human adult
living organism." THE AMERICAN HERITAGE DICTIONARY 675 (2d ed. 1991).
32. See Thomas, supra note 30, at 265-66.
33. See id. at 266.
34. See id. (citing Helen Bequaert Holmes, To Freeze or Not to Freeze: Is
That an Option?, ISSUES IN REPRODUCTIVE TECHNOLOGY 193, 196 (1994)).
35. See id. at 267.
36. See id. at 267-68.
37. See id. at 268.
38. AM. Soc'Y OF REPRODUCTIVE MED. FACT SHEET: IN VITRO
FERTILIZATION (IVF) (Jan. 1998), at http://www.asrm.org/Patients/FactSheets/
invitro.html.
39. Thomas, supra note 30, at 267.
40. See id. The national average for successful pregnancies resulting from the
implantation of cryopreserved embryos is thirteen percent, while the success rates
for implantations of "fresh" embryos range from eighteen percent to twenty-eight
percent depending on the age of the mother. Id. at 267, n.51.
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stem cells (AS cells).4' ES cells are derived from the blastocyst, which is
formed by "totipotent" 42 cells of the early in vitro embryo (first four to
fourteen days).43 EG cells "are derived from primordial germline cells in
early fetal tissue during a narrow window of development [first five to
nine weeks]." 4" AS cells are extracted from human tissue from post-
embryonic development through normal adult life.45
1. ES Cells
Human embryonic stem cells are derived from in vitro embryos during
early development. After a sperm fertilizes an egg, a single totipotent cell
is created. ' During the next several hours, the single totipotent cell
divides into two identical totipotent cells, which continue to divide.47
After approximately four days, the totipotent cells begin to specialize and
form a hollow sphere called a blastocyst.48 The blastocyst consists of an
outer layer of cells as well as an inner cell mass which are the precursors
of the placenta and other supporting tissues necessary for development in
the uterus.49 The inner cell mass cells are pluripotent, meaning they can
develop into virtually any tissue type. However, they cannot, on their
own, develop into a fetus. °
It is from this inner cell mass that ES cells are extracted and subsequent
cell lines are derived. These pluripotent cells are capable of "unlimited,
undifferentiated proliferation in vitro."'" They have three essential
characteristics: "[1] derivation from the preimplantation or
periimplantation embryo, [2] prolonged undifferentiated proliferation,
and [3] stable developmental potential to form derivatives of all three
41. Chapman et al., supra note 8, at 2-4.
42. A totipotent cell is a cell whose potential is total, meaning that it has the
capacity to develop into a complete organism if implanted into a uterus. NAT.
INSTITUTES OF HEALTH, STEM CELLS: A PRIMER (2000) at
http://www.nih.gov/news/stemcell/primer.htm [hereinafter PRIMER].
43. Thomson et al., supra note 4, at 1145.
44. Chapman et al., supra note 8, at 3.
45. Id. at 3-4.





51. Thomson et al., supra note 4, at 1145 (citations omitted).
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embryonic germ layers even after prolonged culture."52 The reason ES
cells are capable of prolonged proliferation is their expression of high
telomerase activity. 3 High levels of telomerase activity are associated
with high replicative life spans in human cell lines, which suggests that
embryonic stem cells have the potential to proliferate indefinitely in
vitro.'4
The ability to grow these cells in culture indefinitely represents a major
step toward realizing the goal of "[a] renewable, tissue culture source of
human cells capable of differentiating into a wide variety of cell types."5
The characteristics which are unique to ES cell lines, including their
longevity and pluripotency (the ability to specialize into virtually any cell
type in the human body), engender them with the highest potential for
therapeutic application."
2. EG Cells
Embryonic germ (EG) cells are derived from fetal tissue aborted
between five and nine weeks into development. 7 In November 1998,
researchers at Johns Hopkins University reported their isolation, culture
and partial characterization." The EG cells that were derived show
indications of pluripotency, but their "range of potential fates" was
considered to be limited in comparison to ES cells because they were
much further along in development. 9 Furthermore, the potential and
behavior of these cells is not as well understood due to the fact that there
52. Id.
53. Id. Telomerase is an enzyme produced by dividing cells that is involved in
producing telomeres. Telomeres are repeating sequences of DNA that cap the
ends of chromosomes. Degradation of telomeres is linked to the longevity of cell
lines.
54. Id. See also John Gearhart, Cell Biology: New Potential for Human
Embryonic Stem Cells, 282 SCI. 1061 (1998). It is this characteristic, along with
pluripotency, that make the use of embryonic stem cells preferable to the use of
adult stem cells, which share neither of these characteristics.
55. Gearhart, supra note 54, at 1061.
56. PRIMER, supra note 42, at 4.
57. Chapman et al., supra note 8, at 3.
58. Id. (citing Michael Shamblott et al., Derivation of Pluripotent Stem Cells
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are "fewer data from animal EG cell experiments than from ES cell
experiments.'6
3. AS Cells
Stem cells are also found in developed tissue. Adult stem (AS) cells
are considered "multipotent," meaning that they are only capable of
61developing into a limited number of tissue types.
AS cells can be found in many adult tissues "or in other tissues that
serve as stem cell reservoirs." 62 One example is adult hematopoietic stem
cells, which can be found in adult bone marrow as well as other tissues."'
Another example is adult neural stem cells, which have recently been
shown to have the potential to "generate progeny of various lineages,"
including adopting a "muscle fate in vitro."' However, the adult neural
stem cells only showed signs of this ability when cultured in the presence
of ES cells. 61 Under identical conditions, but in the absence of the ES
cells, the adult neural stem cells failed to indicate the ability to assume a
muscle fate in vitro.66 While AS cells, present in every developed human
being, "have the capacity for renewal after trauma, disease, or aging,, 67 it
has not yet been demonstrated that they have the "developmental
repertoire" of ES cells outside the embryonic environment. 68
B. Potential Therapeutic Applications of Various Stem Cell Types
The extraordinary progress made with regard to stem cell research
during late 1998 and throughout 1999 prompted Science magazine to label
those achievements "1999's Breakthrough of the Year., 69  Stem cell
60. Id.
61. Chapman et al., supra note 8 at 4.
62. Mark F. Pittenger et al., Multilineage Potential of Adult Human
Mesenchymal Stem Cells, 284 Sci. 143 (1999).
63. Id.
64. Diane L. Clark et al., Generalized Potential of Adult Neural Stem Cells,
SCIENCE, June 2, 2000, at 1660. "Adopting a muscle fate in vitro" is when the stem
cells become muscle cells in the petri dish.
65. Id. at 1661.
66. Id.
67. Pittenger, supra note 62, at 143.
68. Clark, supra note 64, at 1662-63.
69. Gretchen Vogel, Breakthrough of the Year: Capturing the Promise of
Youth, 286 SCI. 2238 (1999).
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research "raises hopes of dazzling medical applications," 70 including
potential treatments that might ease or entirely eliminate suffering from
cardiovascular diseases, autoimmune diseases, diabetes, osteoporosis,
cancer, Alzheimer's disease, Parkinson's disease, severe burns, spinal cord
71injuries and birth defects. Moreover, it might be possible to utilize stem
cells to grow tissue for transplantation.7 However, different stem cell
types (AS), have demonstrated characteristics that could limit their
application.
The ethical considerations surrounding the use of ES cells (derived
from the early in vitro embryo) and EG cells (derived from aborted fetal
tissue) do not apply to AS cells, which can be derived from adult human
tissue.73 The presence of stem cells in adult humans does not, however,
obviate the ethical dilemma. Studies show that, even though AS cells have
tremendous therapeutic applications on their own accord,74 they do not
appear to approach the level of "malleability" unique to ES cells.75
Although adult stem cells do display the capability to differentiate at a
level approaching that of ES cells, other characteristics further limit their
application. For example, unpublished research from scientists at the
University of Minnesota suggests that stem cells extracted from adult
bone marrow are capable of forming brain and liver cell precursors, as
70. Id.
71. NAT'L. INSTITUTE OF HEALTH, NAT'L CANCER INSTITUTE, INSTITUTES
AND CENTERS ANSWERS TO THE QUESTION: "WHAT WOULD YOU HOPE TO
ACHIEVE FROM HUMAN PLURIPOTENT STEM CELL RESEARCH?" (Apr. 26, 2000),
available at http://www.nih.gov/news/stemcell/achieve.html [hereinafter NIH FACT
SHEET]. These diseases currently affect approximately 128.4 million Americans
alone. Perry, supra note 9, at 1423.
72. Perry, supra note 9, at 1423 (T.1); see also Gill Donovan, Stem Cell
Funding Renews Debate, NAT'L CATH. REP., Sept. 8, 2000, at 6.
73. Vogel, supra note 69, at 2238; Donovan, supra note 72, at 6.
74. Along with their recognized potential, adult stem cells are used in at least
one already existing area of therapy. Adult hemotopoietic stem cells are presently
utilized to treat patients suffering from hematological malignancies, including
chronic myelocytic leukemia, multiple myeloma, chronic lymphocytic leukemia
and non-Hodgkin lymphoma. FRED HUTCHINSON CANCER RESEARCH CENTER,
TRANSPLANTATION BIOLOGY, at 3 available at
http://www.fhcrc.org/science/scientific-report/clinical/transplantation/ (last
modified Jan 9, 1998).
75. Gretchen Vogel, Can Old Cells Learn New Tricks?, 287 SCI. 1418 (2000);
Pittenger, supra note 62, at 143; Clark, supra note 64, at 1660-63.
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well as three types of muscle tissue-heart, skeletal and smooth.76
However, these types of versatile adult bone marrow stem cells are
extremely rare, perhaps one in ten billion show such promise.7
Furthermore, adult stem cells "seem to lose their ability to divide and
differentiate after a time in culture., 78 The short "shelf-life" of AS cells
"might make them unsuitable for some medical applications., 79 Dr.
Margaret Goodell, a stem cell biologist at Baylor University, says," [t]here
are adult cell types that may have the potential to repopulate a number of
different types of tissues, but that does not mean they are ES cells.
Embryonic stem cells have great potential. The last thing we should do is
restrict research."8 While recent findings are promising and suggest that
adult stem cell research should continue, the vast majority of available
data indicates that "[aldult stem cell therapies will complement, but
cannot replace, therapies that may be eventually obtained from ES
cells."81
By contrast, "[t]here is no doubt that human [pluripotent stem cells]
76. Vogel, supra note 73, at 1419.
77. Id.
78. Id. See also Clive Cookson, The British Experiment: By Approving the
Use of Embryonic Stem Cells for Medical Research, the House of Lords has put the
UK in a Position to Pioneer New Techniques-and Face Ethical Scrutiny, FIN.
TIMES (London), Jan. 24, 2001, at 24 (quoting a member of the Royal Society,
Britain's National Academy of Sciences:
Adult stem cells are typically present only in small numbers and replicate
at relatively low rates because they are self-programmed to maintain the
function of fully developed organs and tissues. Embryonic and fetal stem
cells are more prolific and versatile and are therefore more likely to
generate sufficient tissue to replace severely damaged parts of the body.)
Id.
79. Vogel, supra note 75, at 1419.
80. Id. (emphasis added). In an ironic twist, opponents of embryonic stem
cell research have cited the work of Dr. Goodell to support their contention that
adult stem cells are as promising, if not more so, than embryonic stem cells. The
Coalition of Americans for Research Ethics went so far as to invite her to speak
on their behalf at a congressional briefing in Washington, D.C. See id. See also
George F. Will, Scruples and Science, WASH. POST, Jan. 20, 2000, at A23; Hannah
M. Vick, Embryonic Stem Cell Research: Ethically Wrong Treatment of the Tiniest
of Humans, CONCERNED WOMEN FOR AMERICA (May 2000), at
http://www.cwfa.org/library/life/2000-05-pp-stem-cell.shtml
81. Chapman et al., supra note 8, at 4.
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possess enormous potential for transplantation therapies." 2 Both EG
cells and ES cells have several potential applications, including helping to
better understand human development, improving gene therapy,
expanding the way we test and develop new drugs and, most importantly,
generating cells and tissue to be used in transplantation therapies."
Because federal funding for embryonic stem cell research has only just
begun and the ability to sustain ES and EG cell lines indefinitely in
culture was only recently achieved, practical applications are merely
speculative at this point.8 Nevertheless, research utilizing ES cells
85extracted from animals suggests a wide range of possible treatments.
Collaborating researchers from the University of Bonn Medical Center,
the National Institute of Neurological Disorders and Stroke in Bethesda,
Maryland, 86 and the University of Wisconsin reported in July 1999 that
they were able to create "normal looking myeline" in the brains of mice
who lacked myeline 8' by injecting their brains with ES cells derived from
mouse embryos.8 With respect to potential applications in humans, the
scientists concluded that "[t]he availability of human ES cells and the
possibility of generating autologous ES cells by nuclear transfer provide
exciting perspectives for the treatment of human diseases."89  The
prospects of their research portend treatment of a range of neurological
disorders, including multiple sclerosis, 9° a debilitating disease affecting
more than 300,000 Americans.9'
82. Wang, supra note 9, at e134.
83. Primer, supra note 42, at 2-3.
84. Vogel, supra note 75, at 1418.
85. See id.
86. The National Institute of Neurological Disorders and Stroke is an arm of
NIH.
87. Myelin is the material that makes up the "myelin sheath" of nerve axions.
The myelin sheath is "an insulating layer surrounding vertebrate peripheral
neurons, that dramatically increases the speed of conduction." ON-LINE MEDICAL
DICTIONARY (1997), at http://www.graylab.ac.uk/cgi-bin/omd.
88. Oliver BrUstle et al., Embryonic Stem Cell-Derived Glial Precursors: A
Source of Myelinating Transplants, 285 Sci., 754-56 (1999).
89. Id. at 756.
90. See id.
91. See NATI'L MULTIPLE SCLEROSIS SOC'Y MS THE DISEASE, at
http://www.mationalmssociety.org/ms%20the%20disease.asp (last visited Jan 3,
2002).
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Another dramatic example of a potential ES cell application was
reported in December 1999. Researchers at Washington University in St.
Louis were successful in restoring some mobility in rats with spinal cord
injuries.9 The injuries were induced in laboratory rats and then treated
by implanting immature nerve cells that had been coaxed into
development from ES cells extracted from mouse embryos.93  The
researchers were astonished at the results, because "no one had ever seen
any improvement in locomotion from an attempt to repair damage to the
spinal cord more than 24 hours after an injury."94 Oswald Steward, a
spinal cord researcher at the University of California, labeled "the work
'compelling' and 'an obligatory first step toward a transplantation therapy
for spinal cord injury' based on embryonic stem cells." 95
Laboratory success like that achieved in the studies described above
apparently represents only the tip of the proverbial iceberg of the
potential applications of ES and EG cell therapies. The ability of ES and
EG cells to perpetuate themselves indefinitely in culture, as well as their
potential to develop into virtually any tissue type in the human body,
suggests staggering possibilities. In a paper released in November 1999,
the American Association for the Advancement of Science details several
examples of disorders that are potentially treatable using ES and EG stem
cell therapy. These disorders include Type 1 diabetes in children, nervous
system diseases, immunodeficiency diseases, including immune
deficiencies suffered as a result of Acquired Immune Deficiency
Syndrome (AIDS), diseases of bone and cartilage and cancer. 96 The
paper also describes the research potential of embryonic stem cell
biology, including a greater understanding of human developmental
biology, as well as a better understanding of pathogenic viruses,
transplantation and gene therapy.97
92. Ingrid Wickelgren, Stem Cells: Rat Spinal Cord Function Partially
Restored, 286 Sci., 1826 (1999).
93. Id. at 1827.
94. Id.
95. Id. at 1826.
96. Chapman, supra note 8, at 5-6.
97. See id. at 6-7.
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II. FEDERAL GOVERNMENT INVOLVEMENT IN STEM CELL
RESEARCH
A. Legislative Background
Since the late 1970's, a de facto moratorium on federal funding of
human embryo research has been in place.98 Pursuant to federal
regulations in effect at the time, Congress authorized funding of such
research only if approved by an Ethical Advisory Board (EAB) appointed
by the Department of Health and Human Services. 99 The only EAB
appointed to evaluate human embryo research existed between 1978 and
1980. This EAB panel concluded that "the research was ethically
acceptable in the abstract provided certain guidelines were followed."
1' °
Despite the approval, the National Institutes of Health (NIH) never
requested funds for a specific project subsequent to that approval9
Furthermore, following the election of Ronald Reagan as president in
1980, the terms of the then-current EAB members were allowed to lapse
and no other EABs were appointed to explore the issue. Thus, no federal
funding was ever provided.'02
In 1993, Congress acted to nullify the regulatory requirements through
the National Institutes of Health Revitalization Act by removing the
98. Christine L. Feiler, Human Embryo Experimentation: Regulation and
Relative Rights, 66 FORDHAM L. REV. 2435, 2459 (1998); see also, R. Alta Charo,
The Hunting of the Illusive Snark: The Moral Status of Embryos, Right-to-Lifers,
and Third World Women: The Search for a Definitive, Intrinsic Moral Status of the
Embryo Is as Doomed as the Hunting of the Illusive Snark, 6 STAN. L. & POL'Y
REV. 11,13 (1995).
99. Feiler, supra note 98, at 2459; Charo, supra, note 98 at 13; see also 45
C.F.R. § 46.204(d) (1993). Appointees to EABs include "specialists and
representatives of the general public who evaluate the medical, legal, social, and
other issues related to the subject matter of incoming grant applications." Feiler,
supra note 98, at 2458, n.211.
100. June Coleman, Playing God or Playing Scientist: A Constitutional
Analysis of State Laws Banning Embryological Procedures, 27 PAC. L.J. 1331, 1338
(Spring 1996).
101. Id.
102. Charo, supra note 98, at 13.
103. National Institutes of Health Revitalization Act of 1993, Pub. L. No. 103-
43, 107 Stat. 122 (codified in scattered sections of 42 U.S.C.) (Revitalization Act).
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EAB approval requirement.'0 At the time, Congress viewed embryo
research as a promising area. Some members were concerned that the
federal regulatory framework would hinder embryo research and leave
privately funded researchers to proceed without adequate medical or
ethical oversight. 5
In the wake of the Revitalization Act, NIH established the Human
Embryo Research Panel to investigate not only the moral and ethical
ramifications of funding such research, but also to develop guidelines for
funding and conducting such research.' °6 The panel met six times, heard
testimony from more than forty witnesses and reviewed correspondence
from over 30,000 individual members of the public.i 7 In its September
1994 report, the panel recommended that surplus human embryos left
over from IVF treatments and donated voluntarily by parents should be
used for research purposes." The panel went further, recommending that
the deliberate creation of human embryos for research purposes be
allowed.'9 The panel's report was approved in its entirety by the
Advisory Committee to the Director of NIH (ACD) in December 1994,
and passed on to the Director himself, Harold Varmus."0 However, hours
after the ACD voted to approve the report, the Clinton Administration
decided to forgo any federal funding for the creation of human embryos
for scientific research.' Although President Clinton publicly directed the
NIH not to allocate funds for the creation of human embryos, the
Administration did not prevent Varmus from renewing funding for
research involving the use of embryos left over from IVF treatments.1
Despite tacit approval from the Clinton Administration, the statutory
window for federal funding created by the Revitalization Act and seventy
104. Feiler, supra note 98, at 2459.
105. See id. (citing H.R. REP. No. 103-28, at 80 (1993)).
106. Coleman, supra note 100, at 1339.
107. Feiler, supra note 98, at 2460 (citing NATIONAL INSTITUTE OF HEALTH,
REPORT OF THE HUMAN EMBRYO RESEARCH PANEL 1, 3 (1994)); see also
Coleman, supra note 100 at 1339.
108. Feiler, supra note 98, at 2460.
109. Charo, supra note 98, at 13.
110. Feiler, supra note 98, at 2460.
111. The Clinton Administration had determined that the deliberate creation
of human embryos for research purposes went too far. Feiler, supra note 98, at
2461-62.
112. Id. at 2461.
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pending proposals for funding, including eight that had cleared scientific
review, NIH was unable to provide any funding for human embryonic
stem cell research.'13 Before NIH had the chance, during the Government
shut down crisis of early 1996, the Republican-led Congress "shoehorned"
a ban on embryo research into an appropriations act designed to keep the
government operational."'
B. The 1996 Ban on Embryo Research
When the Republican party attained a majority in both the House and
Senate in 1994, the atmosphere was ripe for a political challenge to federal
funding for embryo research. As early as March 1995, shortly after NIH
was cleared to provide funds for research involving spare embryos left
over from IVF treatments, the Republican Congress began their attack.
During the government shutdown crisis of 1996, anti-abortion proponents
in the House of Representatives insisted that a ban on research using
embryos be added to any temporary spending bill." 6  In a political
compromise, The Balanced Budget Downpayment Act (1996 Act),
sponsored by Rep. Robert Livingston from Louisiana, was signed into
law." 7 Section 128 of the 1996 Act effectively foreclosed federal funding
of embryo research of any kind.' 8 Subsequent appropriations bills in
113. See id. at 2461; Charo, supra note 98, at 14; Coleman, supra note 100, at
1339; Elizabeth Neus, Scientists Aren't Rushing into Human Embryo Research,
GANNETt NEWS SERVICE, Apr. 4, 1995, LEXIS, Nexis Library, ALLNEWS file.
114. Charo, supra note 98, at 14, n.52 (citing Act of Jan. 26, 1996, Pub. L. No.
104-99, 110 Stat. 96 § 128) (preventing the use of any Federal funds for the
creation of human embryos for research purposes or research in which embryos
are destroyed, discarded or knowingly subjected to risk of injury or death); see
also Charles Krauthammer, HIV Measures Symbolize Republicans' Pettiness,
NEWSDAY, Feb. 6, 1996, at A30.
115. See 141 CONG. REc. H4025-4026 (daily ed. Mar. 30, 1995) (statement of
Rep. Dornan). Congressman Dornan, a conservative Republican from California,
referred to ES cell research as "Frankenstein testing on embryos." Id. at H4025.
116. Shumer, Moody's Issue Warnings on Debt Limit Impasse (CNN
television broadcast, Jan. 25, 1996).
117. Pub. L. No. 104-99 (Jan. 26, 1996); See Coleman, supra note 100, at 1339;
U.S. House of Representatives/Stopgap Spending Bill, AFX NEWS, Jan. 26, 1996,
LEXIS, Nexis Library, ALLNEWS file.
118. The Balanced Budget Downpayment Act, Pub. L. No. 104-99, 110 Stat.
26, § 128. Section 128 read as follows:
SEC. 128. None of the funds made available by Public Law 104-91
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1997" and 1998"' continued to withhold all federal funding of embryo
research.12 '
C. The Clinton Administration
1. The HHS opinion
Dr. Thomson's laboratory success in 1998 prompted the Clinton
Administration to reevaluate the efficacy of the ban. In November 1998,
President Clinton asked the National Bioethics Advisory Commission
(NBAC) to investigate the issues associated with human stem cell
research and to balance all ethical and medical considerations.
12
Furthermore, at the request of Harold Varmus, then Director of NIH, the
Department of Health and Human Services (HHS) took a closer look at
the 1996 Act to determine whether or not it applied to pluripotent stem
cell research. 12 In January of 1999, Harriet Rabb, general counsel for
may be used for -
(1) the creation of a human embryo or embryos for research
purposes; or
(2) research in which a human embryo or embryos are destroyed,
discarded, or knowingly subjected to risk of injury or death greater
than that allowed for research on fetuses in utero under 45 C.F.R.
46.208(a)(2) and 42 U.S.C. 289g(b).
For purposes of this section, the phrase "human embryo or embryos"
shall include any organism, not protected as a human subject under 45
C.F.R. Part 46 as of the date of enactment of this Act, that is derived by
fertilization, parthenogenesis, cloning or any other means from one or
more human gametes.
Id.
119. See Omnibus Consolidated Appropriations Act of 1997, Pub. L. No.
104-208, 110 Stat. 3009 (1997).
120. See Departments of Labor, Health and Human Services, Education and
Related Agencies Appropriations Act of 1998, Pub. L. No. 105-78, 111 Stat. 1467
(1998).
121. Feiler, supra note 98, at 2461, nn.236, 237.
122. NAT'L BIOETHICs ADVISORY COMM'N., ETHICAL ISSUES IN HUMAN STEM
CELL RESEARCH, EXECUTIVE SUMMARY 1, available at
http://www.bioethics.gov/stemcellexecintro.html (1999) [hereinafter ETHICAL
ISSUES].
123. Miranda Biven, Administrative Developments: NIH Backs Federal
Funding for Stem Cell Research, 27 J. L. MED. & ETHICS 95 (1999).
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HHS, determined that the ban did not cover pluripotent stem cell
124research. The legal opinion concluded that pluripotent stem cells do not
fall within the definition of "human embryo" under the Act.12' Rabb's
opinion was based on the Act's characterization of a human embryo as an
"organism." Because the term "organism" was not defined under the
1996 Act or its progeny, Rabb's "legal opinion relie[d] on 'the commonly
accepted or scientific understanding of that term,' namely, 'an individual
constituted to carry out all life functions.", 126 Based on this interpretation,
Rabb concluded that previously extracted embryonic stem cells are not
covered by the statute because, on their own, they lack the capacity to
127develop into an "organism" when implanted in the uterus.
After the HHS released its opinion, the possibility of federal funding
was quickly realized. Acting on the authority of the HHS determination,
NIH Director Varmus convened a thirteen member working group to
devise draft guidelines for conducting pluripotent stem cell research.'2 In
September 1999, the NBAC released its report on the ethical
considerations involved in human stem cell research. The report
concluded that human embryonic stem cell research is legally, ethically
and morally acceptable if certain guidelines are followed. 29  On
December 2, 1999, following the release of the NBAC report, the NIH
working group released its draft guidelines.3° After evaluating public
124. See M. Therese Lysaught, Holy Grail or Pandora's Box?: Evaluating
Human Embryonic Stem Cell Research; Statistical Data Included, WORLD AND I,
Nov. 1, 1999 at 186.
125. "Human embryo," as defined under the 1996 Act and its progeny is: "any
organism, not protected as a human subject under 45 C.F.R. Part 46 as of the date
of enactment of this Act, that is derived by fertilization, parthenogenesis, cloning,
or any other means from one or more human gametes" or human diploid cells.
Pub. L. No. 104-99, 111 Stat. 26, § 128.
126. Miranda Biven, Recent Developments in Health Law: Harvard Law &
Health Care Society: Administrative Developments: NIH Backs Federal Funding
for Stem Cell Research, 27 J.L. MED. & ETHICS 95,96 (1999).
127. Id.
128. Susan Lee, Recent Developments in Health Law: Harvard Law & Health
Care Society: Human Stem Cell Research: NIH Releases Draft Guidelines for
Comment, 28 J.L. MED. & ETHICS 81, 82 (2000).
129. ETHICAL ISSUES, supra note 122, at 3.
130. NAT'L INSTITUTE OF HEALTH, DRAFT GUIDELINES FOR RESEARCH
INVOLVING HUMAN PLURIPOTENT STEM CELLS, 64 Fed. Reg. 67,576 (Dec. 2,
1999).
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comments, NIH published its final guidelines in the Federal Register on
August 25, 2000, which became effective immediately.' The guidelines
were intended to "help ensure that NIH-funded research in [the] area is
conducted in an ethical and legal manner" and to "enhance both the
scientific and ethical oversight of this important arena of research and the
pace at which scientists can explore its many promises.'
132
2. NIH guidelines
In order to ensure compliance with the new guidelines, NIH prescribed
procedural, oversight and documentation requirements and also indicated
exactly which research would be eligible for funding and which research
would not.'33 NIH limited federal funding of pluripotent research to those
cells that "were derived (without federal funding) from human embryos
that were created for the purpose of fertility treatments and were in
excess of the clinical need of the individuals seeking such treatment.'
34
The guidelines also required that no monetary or other inducements be
offered for the donation of excess embryos and that there be a "clear
separation between the decision to create human embryos for fertility
treatment and the decision to donate human embryos in excess of clinical
need for research purposes to derive pluripotent stem cells." '
Furthermore, under the guidelines only those excess embryos that have
been cryogenically frozen could be used.36 Finally, and perhaps most
importantly, the guidelines put the final decision-making authority in the
hands of the individuals whose gametes were used to create the embryos,
i.e., the parents. The guidelines further required that informed consent be°
granted by those individuals who sought the fertility treatment. 137 Before
stem cells derived from excess embryos may be utilized in federally-
funded research, the guidelines stipulated that potential donors should be
informed that the cell lines derived from their excess embryos may be
kept alive for several years, that they may be used in transplantation
131. NAT'L INSTITUTE OF HEALTH, GUIDELINES FOR RESEARCH USING
HUMAN PLURIPOTENT STEM CELLS, 65 Fed. Reg. 51,976 (Aug. 25, 2000)
[hereinafter STEM CELL GUIDELINES].
132. NIH FACT SHEET supra note 71.
133. Id.
134. Stem Cell Guidelines, supra note 131, at 51,979.
135. Id.
136. Id. at 51,980.
137. Id.
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research, that the research may have commercial potential and that the
research is not intended to provide direct benefits to the donors.'38 The
guidelines were subsequently withdrawn in favor of the criteria set forth
by President Bush on August 9, 2001.139
D. Current Legislative Initiatives
1. The 106th Congress
The 106th Congress failed to enact legislation either codifying NIH's
guidelines or specifying that embryonic stem cell research is indeed
illegal. Senator Arlen Specter (R-PA), the chairman of the Senate
Appropriations Labor, Health & Human Services and Education
Subcommittee, introduced legislation in January 2000 that would not only
allow for statutory adoption of the guidelines proposed by the NIH, but
would extend federal funding to actual derivation of stem cells. 14° After
the bill was introduced, it was referred immediately to the Senate
Committee on Health, Education, Labor and Pensions for consideration,
where it remained until September 28, 2000.'t
A vote on Senator Specter's bill, co-sponsored by Senators Tom Harkin
(D-IA) and Ernest Hollings (D-SC), took place prior to Congress' winter
recess because of the failure to achieve a Senate quorum on the date the
142bill was considered. However, prior to the failure to achieve a quorum,
Senator Specter demonstrated the strong bipartisan support for
embryonic stem cell research, even among pro-life senators. Moreover,
138. Id. The guidelines also required that informed consent state that the
donors make the donation without restriction, that information that could identify
the donors be removed prior to derivation, that the donors will receive no
financial remuneration for their donation, and that the embryos donated will not
be implanted into a woman's uterus and will not survive the process. Id.
139. NAT'L INSTITUTES OF HEALTH GUIDELINES FOR RESEARCH USING
HUMAN PLURIPOTENT STEM CELLS, 66 Fed. Reg. 57107 (Nov. 14, 2001); Press
Release, The White House, Fact Sheet: Embryonic Stem Cell Research (Aug. 9,
2001), available at http://www.whitehouse.gov/news/ releases/2001/08/print/
20010809-1.html; see also infra Section II.E.
140. Stem Cell Research Act of 2000, S.2015, 106th Cong. (2000).
141. See BILL SUMMARY AND STATUS, S. 2015, 106th Cong., available at
http://thomas.loc.gov (last visited Dec. 18, 2001).
142. 146 CONG. REC. S9447-48 (daily ed. Sept. 28, 2000).
143. Id. at S9448. Sen. Specter noted for the record that Sens. Strom
20011
Journal of Contemporary Health Law and Policy [Vol. 18:147
Senator Specter stated that the 1996 Act, which contained the prohibition
against the use of federal funds for stem cell research, originated from the
subcommittee that he chairs.'4 His explanation is significant: "When the
prohibition was imposed, there was no one who really knew the
miraculous potential of stem cells .... This [knowledge] only came into
existence with the research disclosed in November of 1998.",
14
2. The 107th Congress
Not a moment was wasted before the issue of federal funding for
embryonic stem cell research was brought to the forefront of the 107th
Congress. On January 30, 2001, a bipartisan bill supporting a
congressional resolution favoring federal funding of embryonic
pluripotent stem cell research was introduced.) Presently, there are no
less than six different bills before the 107th Congress devoted solely to the
issue.
147
Thurmond (R-SC), Gordon Smith (R-OR), and former Sen. Connie Mack (R-
FL), all adamantly "pro-life," have made statements supporting such legislation.
Id. Conservative Republican John McCain is also in favor of supporting stem cell
research. Susan Baer, Bush's Moves on Abortion Issue Chilling to Research
Community; Scientists Fear Funding Curbs for Promising Stem Cells, BALT. SUN,
Feb. 1, 2001, at 1A.
144. 146 CONG. REC. S9448 (daily ed. Sept. 28, 2000).
145. Id.
146. H.R. Con. Res. 17, 107th Cong.(2001)(introducing resolutions by Reps.
Constance Morella (R-MD) and Caroln Maloney (D-NY). There are currently
eighty-four total cosponsors of the resolution. The resolution was intended to
express the support for federal funding of pluripotent stem cell research. Id. The
bill was referred to the House Committee on Energy and Commerce's
Subcommittee on Health on February 14, where it remains).
147. See Stem Cell Research Act of 2001, S. 723, 107th Cong. (Apr. 5, 2001)
(eighteen co-sponsors) (supporting federal funding for research utilizing
embryonic stem cells extracted from embryos donated from invitro fertilization
clinics with the consent of the parents), Stem Cell Research Act of 2001, H.R.
2059, 107th Cong. (June 5, 2001) (companion bill to S. 723) (twenty-nine co-
sponsors), Responsible Stem Cell Research Act of 2001, H.R. 2096, 107"h Cong.
(June 7, 2001) (sixty-eight co-sponsors) (supporting the creation of a "National
Donor Bank" for non-embryonic stem cells), Responsible Stem Cell Research Act
of 2001, S. 1349, 107th Cong. (Aug. 3, 2001) (three co-sponsors) (companion bill of
H.R. 2096), Stem Cell Research for Patient Benefit Act of 2001, H.R. 2747, 107th
Cong. (Aug. 2, 2001) (fifteen co-sponsors) (supporting federal funding for
research according to the guidelines issued by the NIH under the Clinton
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Collectively, these bills display varying degrees of support for federal
funding of embryonic stem cell research. 148 However, it is not a stretch to
suggest that federal funding of embryonic stem cell research enjoys wide-
reaching bipartisan support, considering the pro-federal funding positions
taken by some former self-described pro-life Senators in Congress.149
This legislative activity is due in part to the recent change in
administrations. The election of George W. Bush worried many
advocates of pluripotent stem cell research. President Bush is on record
as an opponent of federal funding for similar research, including research
on fetal tissues retrieved from induced abortions.5
E. The Bush Administration
In a question-and-answer session during a meeting with Democratic
and Republican governors, newly-elected President Bush reiterated his
campaign position that the Federal Government ought not provide
funding for "research from aborted fetuses.' 5 During the same meeting,
President Bush provided a vague response to whether or not he would act
to ban federal funding for embryonic stem cell research by saying "I
believe there's [sic] some wonderful opportunities for adult stem-cell
research."'5 2 The President's Press Secretary, Ari Fleischer, similarly
evaded direct questions on whether President Bush would act to deny
federal funding to embryonic stem cell scientists. Mr. Fleischer responded
to a direct question regarding federal funding for fetal tissue and
embryonic stem cell research during a transition team news briefing by
stating:
During the campaign, President-elect Bush said that he would
oppose using taxpayer funds to support fetal tissue research
Administration) and New Century Health Advantage Act, H.R. 2838, 107h Cong.
(Sept. 5, 2001). See supra Section II.C.
148. Id.
149. See supra note 143. See also, Aaron Zitner and Marlene Cimons, L.A.
TIMES, Jan. 18, 2001, at A13 (noting that former Republican Senator Connie Mack
from Florida has "personally contacted senior members of the Bush team to urge
them not to block the NIH plan.") Id.
150. See Joan Lowy, Where the 4 Candidates Stand on Key Issues, SCRIPPS
HOWARD NEWS SERVICE, Oct. 17, 2000, LEXIS, Nexis Library, ALLNEWS file.
151. Rob Fournier, AP, Bush Says No Federal Funds for Fetal Tissue, Stem
Cells Derived from Abortions, CHATTrANOOGA TIMES, Jan. 27, 2001, at A3.
152. Id.
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from induced abortions. He said that as president he would
oppose federally-funded research or experimentation on
embryonic stem cells that require live human embryos to be
discarded or destroyed.
When pressed further on the issue, Mr. Fleischer limited President
Bush's opposition to federal funding for research or experimentation that
"is done as a result of an induced abortion."'154 At the time, embryonic
stem cell research approved for federal funding neither utilized nor
allowed for the use of embryos that were obtained through induced
abortions.1
5
Bush's sidestepping of the issue raised the hope of scientists and
angered some abortion opponents. Judie Brown, president of the
American Life League, described the President's pre-decision stance as
either "terribly misinformed" or "intentionally misleading."'56 The
feelings of many abortion opponents are summarized by her sentiments:
"He claims to be pro-life. Well, what's his problem?"'
57
Under the NIH's guidelines formulated in connection with the Clinton
Administration's interpretation, the deadline for funding requests was
March 15, 2001.58 That deadline came and went without action from the
Bush Administration. Shortly after, Richard Doerflinger, an outspoken
critic of federal funding for embryonic stem cell research, argued that,
"the timeline will continue and [the government will] fund things that the
president is against."' 59 It turns out that Mr. Doerflinger was partially
correct.
Given President Bush's campaign statements and the vagaries
153. FED. DOCUMENT CLEARING HOUSE, POLITICAL TRANSCRIPTS, ARI
FLEISCHER HOLDS NEWS BRIEFING, Jan. 4, 2001.
154. Id.
155. STEM CELL GUIDELINES, supra note 131, at 51,979.
156. Jodi Enda, Both Sides Fear for Future of Stem-Cell Research, KNIGHT
RIDDER/TRIB NEWS SERVICE, Feb. 5, 2001, LEXIS, Nexis Library, ALLNEWS
file.
157. Id.
158. NAT'L INSTITUTES OF HEALTH, APPROVAL PROCESS FOR THE
DOCUMENTATION OF COMPLIANCE WITH NIH GUIDELINES ON THE USE HUMAN
PLURIPOTENT STEM CELLS IN NIH RESEARCH PROPOSED FOR SUPPORT UNDER
GRANTS AND COOPERATIVE AGREEMENTS, Notice OD-01-003, (Nov. 21, 2000),
available at http://www.nih.gov/news/stemcell/NOT-OD-00-050.html.
159. Enda, supra note 156.
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propounded by members of his staff during the first few months of his
administration, it was no wonder that both supporters and opponents of
embryonic stem cell research were beset by anxiety. Moreover, a further
blurring of the administration's position on federal funding for embryonic
stem cell research came with confirmation (by a unanimous vote) of
Tommy Thompson as Secretary of HHS. As governor of Wisconsin,
Secretary Thompson, a Republican and stated opponent of abortion,
"championed privately financed stem cell research at the University of
Wisconsin."' 6  During his State of the State address in 1999, then-
governor Thompson heralded the work of Dr. James Thomson, the first
to isolate and culture embryonic stem cells, as a "bold pioneer" in a field
of research that would help "to combat Parkinson's disease and childhood
diabetes, and one day grow human organs for transplants., 161 As recently
as March 2001, Secretary Thompson stated under Senate questioning that
he is "troubled" by the 1996 Act and its ban on research involving human
embryos.
Research advocates and scientists had been cautiously optimistic
regarding Thompson's nomination. They saw his vocal support for the
science and his political pragmatism as positive indicators that he would
not act to ban federal funding for a number of requests that would be
162
submitted to NIH by March 15, 2001. As that date passed, and with the
moratorium imposed by the administration on any review of the proposals1 r 63
that were submitted by the March 15 deadline, speculation intensified.
Supporters saw political pressure from the right as a serious threat to
federal funding for embryonic stem cell research, and, as it turns out, they
too were correct in part'
160. Id.
161. Nancy McVicar, A Question of Life and Health; Moral Concerns About
Stem Cell Research Will Lead to a Review by President Bush and His New
Secretary of Health and Human Services, SUN-SENTINEL (Fort Lauderdale, Fla.),
Jan. 28, 2001, at 1G.
162. Craig Gilbert, Tones Differ in Nominees' Senate Hearings; Issues, not
Clashes, Are Awaiting Thompson, MILWAUKEE J. SENTINEL, Jan. 18, 2001, at 1A.
163. See Rick Weiss, Bush Administration Order Halts Stem Cell Meeting
NIH Planned Session to Review Fund Requests, WASH. POST, Apr. 21, 2001, at A2.
164. Sharon Schmickle, Medical Scientists Welcome HHS Nominee; Several
Researchers Say Tommy Thompson's Passion for Biotechnology May Offset the
Influence His Abortion Stance Will Have on Such Research as Embryo Stem-Cell
Studies, STAR TRIB. (Minneapolis, Minn.), Jan. 5, 2001, at 10A.
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Jeffrey Kahn, director of the Center for Bioethics at the University of
Minnesota noted that "[a]ll it takes to change [federal funding for
embryonic research] is for George W. Bush to sign a different executive
order."' 65 That is exactly what happened.
On August 9, 2001, President Bush ended the speculation in a
nationally-televised address devoted solely to his administration's
decision on whether to provide federal funding for embryonic stem cell
research.' 66 In what can only be described as a politically expedient
maneuver, the Bush Administration chose a path that provides for limited
federal funding of embryonic stem cell research. This decision fully
satisfies only a few of those in favor of such research.167
The President's plan allows for federal funds "to be used for research
on... existing stem cell lines, where the life-and-death decision has
already been made."' '6 As further explained in subsequent papers issued
by NIH, the plan contemplates federal funding for research utilizing some
sixty-four embryonic stem cell lines that already exist.' 69 Funding for
research involving stem cells that were derived after the President's
address will not be permitted. 70 The administration has identified what it
deems to be sixty-four separate, viable embryonic stem cell lines that exist
in ten different laboratories throughout the world.17' However, serious
165. Id.
166. See National Address, supra note 18, at A12.
167. Michael E. Ruane, Stem Cell Decision Only Adds to Debate; President's
Plan to Allow Research Angers Many, but Others Decry Its Limits, WASH. POST,
Aug. 11, 2001, at B1.
168. National Address, supra note 18, at A12.
169. NAT'L INSTITUTES OF HEALTH, UPDATE ON EXISTING HUMAN
EMBRYONIC STEM CELLS, (Aug, 27, 2001) available at
http://www.nih.gov/news/stemcell/082701Iist.htm [hereinafter UPDATE].
170. Id. at 2. In order to be eligible for funding, the derivation process to
obtain embryonic stem cells must have been initiated prior to 9:00 EDT on
August 9, 2001, the exact time that President Bush addressed the nation.
171. Id. These sixty-four lines are reported to exist at the following
laboratories: BresaGen, Inc., Athens, Georgia (four lines); CyThera, Inc., San
Diego, California (nine lines); Karolinska Institute, Stockholm, Sweden (five
lines); Monash University, Melbourne, Australia (six lines); National Center for
Biological Sciences, Bangalore, India (three lines); Reliance Life Sciences,
Mumbai, India (seven lines); Technion-Israel Institute of Technology, Haifa,
Israel (four lines); University of California, San Francisco, California (two lines);
Gbteborg University, GOteborg, Sweden (nineteen lines); Wisconsin Alumni
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questions have been raised regarding the Bush Administration's
characterizations of the viability and usefulness of these lines, as well as
their availability to U.S. researchers."'
Only time will tell if the Bush Administration's decision on federal
funding will prove effective.173 President Bush's policy, however, offers
little solace for both those who support and those who oppose federal
funding. Cardinal Theodore E. McCarrick, the Roman Catholic
Archbishop of Washington, D.C., views any "allotment of federal
funding.., for [embryonic stem cell research] to be morally wrong," while
Betty Ann Krahnke, who suffers extensive paralysis as a result of Lou
Gehrig's disease, feels that the Bush Administration should have gone
further in their support for the research.' The Bush Administration's
policy neither provides assurance that the research will be thoroughly
supported, nor does it provide any protection to those who believe it to be
morally wrong.
Research Foundation, Madison, Wisconsin (five lines). See also Press Release,
Tommy G. Thompson, Secretary of Health and Human Services (Aug. 27, 2001)
(regarding stem cell lines) (on file with author).
172. See, e.g., Ceci Connolly & Rick Weiss, Stem Cell Colonies' Viability
Unproven; Some in NIH List of 64 Termed Young, Fragile, WASH. POST, Aug. 28,
2001, at Al; T.R. Reid, U.S. Count of Stem Cell Lines Surprised Swedes, WASH.
POST, Aug. 30, 2001 at A20 (noting that Swedish fertility expert Lars Hamberger
of Goteborg University identified only "three defined cell lines, and four that
[they] are trying to develop, and perhaps a dozen others that could possibly be
developed in the future.") (emphasis added). This seriously belies the so-called
nineteen "viable" embryonic stem cell lines identified by the administration as
existing at Goteborg University.); Ceci Connolly, Justin Gillis & Rick Weiss,
Viability of Stem Cell Plan Doubted; Bush Policy Could Limit Research, Scientists
Say, WASH. POST, Aug. 20, 2001 at Al; Gina Kolata, Researchers Say Embryos In
Labs Aren't Available, N.Y. TIMES, Aug. 26, 2001, at Al; How Many Lines?,
Editorial, WASH. POST, Aug. 31, 2001, at A22.
173. See David Brown, Stem Cell Decision Examined; Scientists Are
Wondering About Its Impact on Their Work, WASH. POST, Aug. 12, 2001, at A8.
174. Michael E. Ruane, Stem Cell Decision Only Adds to Debate; President's
Plan to Allow Research Angers Many, but Others Decry Limits, WASH. POST, Aug.
11, 2001, at B1.
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III. THE LEGAL, MORAL AND ETHICAL CONSIDERATIONS
In civilized life, law floats in a sea of ethics."5
A. The Legal Status of the Human Embryo In the United States
Although the topic has been commented on in great depth, there are
few decisions or statutes that purport to define the legal status of human
embryos. There is certainly no consensus among American jurisdictions
that have attempted to do so."' What little jurisprudence that does exist
generally arises in the context of the legal status of extracorporeal
(outside the womb) embryos cryopreserved through infertility
treatments.
1 77
There appear to be three possible views on the legal status of the
embryo: (1) embryos as "juridicial persons"; (2) embryos as property; and
(3) embryos as neither juridicial persons nor property, but deserving of
"special respect."178
175. SIMPSON, supra at note 26 (quoting United States Supreme Court Chief
Justice Earl Warren, N.Y. TIMES, Nov. 12, 1962).
176. See, e.g., LA. REV. STAT. ANN. § 9:123 (West 1991) (defining the human
embryo as a "juridicial person"); Davis v. Davis, 942 S.W.2d 588, 594-95 (Tenn.
1992) (refusing to accord "preembryos" legally cognizable interests as persons
under Tennessee law).
177. See generally Heidi Forster, The Legal and Ethical Debate Surrounding
the Storage and Destruction of Frozen Human Embryos: A Reaction to the Mass
Disposal in Britain and the Lack of Laws in the United States, 76 WASH. U.H.L.Q.
759 (1998).
178. See Thomas, supra note 30 (identifying these three possibilities as
potential legal classifications of the status of the embryo and arguing that
abandoned frozen embryos should be treated as property under Texas law);
Patricia A. Martin & Martin L. Lagod, The Human Preembryo, the Progenitors,
and the State: Toward a Dynamic Theory of Status, Rights, and Research Policy, 5
HIGH TECH. L.J. 257, 261 (1991) (identifying three possible legal classifications for
embryo status); Alise R. Panitch, Note, The Davis Dilemma: How to Prevent
Battles Over Frozen Preembryos, 41 CASE W. RES. L. REV. 543, 553 (1991) (noting
that scholars will pick either person, property or neither in commentary); Weldon
E. Havins & James J. Dalessio, The Ever-Widening Gap Between the Science of
Artificial Reproductive Technology and the Laws Which Govern that Technology,
48 DEPAUL L. REV. 825, 835 (1999) (noting the three legal classifications of the
status of the embryo).
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1. Embryos as "juridicial persons"
The reasoning that embryos should be treated as "juridicial persons"
emanates primarily from the anti-abortion movement. This movement,
associated with Christian doctrine and tradition, particularly Roman
Catholic, believes that a human being with cognizable legal rights is
created upon conception.79 Courts have not adopted this position, and
generally view the legal status of the embryo, whether in utero or
extracorporeal, either in the context of property rights or the non-
property "special respect" category.""
o T • • 181
Apart from the law of Louisiana, American jurisprudence has balked
at the idea of the embryo as a "juridicial person." Beginning with the
seminal Supreme Court decision in Roe v. Wade, 18 courts have refused to
recognize the embryo or nonviable fetus as a person with cognizable legal
rights. The Court held in Roe that prior to viability (at the end of the first
trimester of pregnancy), states have no "compelling" interest in protecting
any legal interests of the potential life because, presumably, the embryo
or fetus has no chance for survival outside of the womb. This holding
placed viability over conception as the threshold for the recognition of
cognizable rights. In Planned Parenthood v. Casey,'84 though rejecting the
trimester approach, the High Court sustained the central holding of Roe,
reiterating its recognition of viability, not conception, as the
developmental watershed for determining the legal status of the embryo
179. Thomas, supra note 30; see generally POPE JOHN PAUL II, EVANGELIUM
VITAE (THE GOSPEL OF LIFE) (1995) [hereinafter EVANGELIUM VITAE].
180. Thomas, supra note 30.
181. See LA. REV. STAT. ANN. § 9:123 (West 1991); see also Havins and
Dalessio supra note 178, at 845. It is noteworthy that all three of the state statutes
that have criminalized embryo experimentation have been held unconstitutionally
void for "vagueness." Margaret S. v. Edwards, 794 F.2d 994 (5th Cir. 1986)
(holding that a Louisiana statute that criminalized non-therapeutic
experimentation on embryos was held unconstitutionally vague for the failure to
properly define the terms "experiment" and "therapeutic"); Jane L. v. Bangerter,
61 F.3d 1493 (10th Cir. 1995) (holding that a Utah statute criminalizing embryo
experimentation unconstitutionally vague for failure to properly define the terms
"experimentation" and "benefit"); Lifchez v. Hartigan, 735 F. Supp. 1361 (N.D.
I11. 1990) (holding an Illinois statute criminalizing embryo research
unconstitutionally vague for failure to define the term "therapeutic").
182. Roe v. Wade, 410 U.S. 113 (1973).
183. Id. at 163.
184. Planned Parenthood v. Casey, 505 U.S. 833 (1992).
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or fetus.
8 1
While neither Roe nor Casey address directly the legal status of
extracorporeal embryos, they both stand for the proposition that embryos
are not juridicial persons. This proposition is rooted in pervasive judicial
recognition that a woman's right to terminate her pregnancy during the
period of nonviability overrides the state's interest in protecting nonviable
human life. Consequently, both Roe and Casey provide an analytical
framework for evaluating the legal status of the extracorporeal embryo
either as the property of the gamete providers (the biological parents) or
as an entity, not endowed with the full legal rights of a developed
juridicial person, but deserving of special respect.
2. Embryos as property
Defining embryos as property in order to evaluate their legal status
does not necessarily entail equating them to tangible or physical property
as the traditional notion might suggest. Instead, the definition provides a
means of determining who has ultimate control over their disposition. 86
Courts that have addressed the question of dispositional authority over
frozen embryos have relied on the tenets of both property and contract
law.' 87
The first case in the United States to deal with the legal issues
surrounding the disposition of extracorporeal embryos was Del Zio v.
Presbyterian Hospital of New York.' 8 The Del Zios, unsuccessful in their
attempts to have a child due to blockages in Mrs. Del Zio's fallopian
185. Id. at 870-73.
186. John A. Robertson, Reproductive Technology and Reproductive Rights:
In the Beginning: The Legal Status of Early Embryos, 76 VA. L. REV. 437, 455 n.48
(1990). Robertson states that
'property' and 'ownership' are for some persons loaded, charged, or even
pejorative terms, which use of the term 'quasi-property' only partially
eases. Having a property or ownership interest in early embryos,
however, should not be thought of as identical to having a property
interest in furniture or cars, though there are many similarities.
Id. Robertson clarifies further by stating that "applying such terms as 'ownership'
or 'property' to early embryos risks misunderstanding. Such terms do not signify
that embryos may be treated in all respects like other property." Id. at 454.
187. See infra notes 183-221 and accompanying text.
188. Del Zio v. Presbyterian Hosp. of N.Y., No. 74 Civ. 3588, 1978 U.S. Dist.
LEXIS 14450 (S.D.N.Y. Nov. 9, 1978).
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tubes, learned of and pursued the then experimental procedure of in vitro
fertilization through their doctor at Presbyterian Hospital in New York. 9
On September 12, 1973, Mrs. Del Zios underwent the procedure to
extract and fertilize her eggs.'O The fertilized eggs were subsequently
placed in an incubator, where they were to remain for four days.'9' When
the department supervisor doctor (Dr. Vande Wiele) learned of it, he
ordered the culture removed from incubation and placed in deep freeze,
which effectively destroyed the culture.192
The Del Zios sued Vande Wiele and Presbyterian under two separate
theories: intentional infliction of emotional distress and conversion. The
jury ultimately found for the Del Zios, and awarded them damages in
excess of $50,000 for intentional infliction of emotional distress.'94 The
conversion theory was based on the argument that the fertilized egg in
culture was their property, and Vande Wiele's destruction of the culture
interfered with their rights over that property. As to the theory of
conversion, the jury found for the defendants.'9  On appeal of the
verdicts, however, the Federal District Judge noted that "[tihe jury could
reasonably have found liability on the conversion claim, but rendered a
verdict for defendants on the basis that the amount of the damage for
conversion was too speculative to be determinable."'%
The next case to recognize the property interest of the gamete
providers in the disposition of frozen embryos created through an IVF
procedure was York v. Jones. In York, the Eastern District of Virginia
upheld a breach of contract action brought by the Yorks against a fertility
clinic in Norfolk, Virginia.! The Yorks sought infertility treatment at the
189. Id. at *2-3.
190. Id.
191. Id.
192. Id. Dr. Vande Wiele, Chief of the Obstetrical and Gynecological Service
at Presbyterian Hospital, consulted with his superiors regarding the procedure and
they all agreed that the procedure, which had not been approved, should be
stopped. Id. at *3-4.
193. Id. at *1.
194. Id. at *11.
195. Id.
196. Id. at *16.
197. York v. Jones, 717 F. Supp. 421 (E.D. Va. 1989).
198. Id. at 423.
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Jones Institute for Reproductive Medicine (Institute). 199 They underwent
four unsuccessful attempts at IVF at the Institute. Prior to the fourth
attempt, however, and in anticipation of further attempts in the future,
the Yorks signed an informed consent agreement (Cryopreservation
Agreement) which detailed the couple's rights in any frozen embryos
generated by the treatment.2°1 As a result of the fourth and last attempt at
IVF at the Institute, six eggs were fertilized. Five were implanted, but
none resulted in a successful pregnancy. The last remaining embryo was
cryogenically frozen.2 °3
During the course of IVF treatment at the Institute, the Yorks moved
to California. In May, 1988, the Yorks sought to have their last remaining
frozen embryo transferred to a clinic in Los Angeles, California. 2°4 The
Institute refused to transfer the frozen embryo, stating that the
Cryopreservation Agreement did not establish any protocol for inter-
institutional transfer.20' The Yorks subsequently filed suit claiming breach
of contract. The Virginia court sided with the Yorks, adopting their
argument that the Cryopreservation Agreement recognized the Yorks'
property interest in the frozen embryo. 20 The court held that the
Cryopreservation Agreement created a bailment contract, and that the
Yorks, as bailors, exercised ultimate control over the disposition of the
frozen embryo.'07 The court in York, therefore, recognized the property
interest of the gamete providers in frozen embryos, and interpreted the
Cryopreservation Agreement as a legally enforceable contract.
The question of control over the ultimate disposition of frozen embryos
208arose again in Kass v. Kass. In Kass, the Court of Appeals of New York
held that, in the presence of a valid, legally enforceable informed consent
agreement detailing dispositional authority over frozen embryos, the
199. Id.
200. Id. at 423-24.
201. Id. at 424. The relevant portion of the cryopreservation agreement
stated that the Yorks had "principle responsibility to decide the disposition" of




205. Id. at 425.
206. Id.
207. Id.
208. Kass v. Kass, 696 N.E.2d 174 (N.Y. 1998).
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language of the agreement controls. 9 Prior to their divorce, the Kasses
underwent an IVF treatment that yielded five frozen embryos.210 After
the divorce, Maureen Kass sued for possession of the frozen embryos on
the basis that it was her only chance for genetic motherhood.2" Steven
Kass claimed that the informed consent agreement that the couple signed
212with the fertility clinic controlled. The informed consent agreement
vested dispositional authority over the frozen embryos in the IVF clinic
should the couple, no longer desiring implantation, be unable to arrive at
a decision regarding the disposition of their frozen embryos. 2" The court
determined that the language of the consent agreement controlled, and
granted dispositional authority over the embryos to the IVF clinic.
211
In arriving at its holding, the New York Court of Appeals again
concluded that frozen embryos are not recognized as "persons" for
constitutional purposes. 211 After expounding on the "abundant
commentary" regarding the disposition of the embryos, the court
determined that because this was a contractual issue, it did not have to
define the legal status of embryos. 21' Furthermore, the court declined to
decide whether embryos are entitled to "special respect., 217 Although the
court did not explicitly categorize frozen embryos as property, its holding
regarding the controlling aspect of the informed consent agreement over
the dispositional authority of the frozen embryos suggests a property
209. Id. at 179.
210. Id. at 175.
211. Id.
212. Id. The informed consent agreement that the couple signed stated that,
in the event of divorce the disposition of the embryos would be determined in a
property settlement. If the couple should decide to forgo implantation of the
frozen embryos, or were unable to reach a decision regarding their disposition,
authority over the disposition of the frozen embryos would vest in the IVF
program. Id. at 176-77. In arriving at its decision, the court cited Davis v. Davis,
842 S.W.2d 588 (Tenn. 1992) to support the proposition that both gamete
providers, the mother and the father, enjoy procreative autonomy, which
"includes an interest in avoiding genetic parenthood as well as an interest in
becoming a genetic parent." Kass, 696 N.E.2d at 178. For a more detailed
analysis of the holding in Davis, see infra Part III.A.3.
213. Kass, 696 N.E.2d at 176-77.
214. Id. at 182.
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218metaphor with regard to the legal status of frozen embryos.
3. Embryos as neither persons nor property, but deserving of
"special respect"
Increasingly, commentators, institutions, and courts may be inclined to
classify the embryo as neither person nor property, but as a physical entity
deserving of "special respect. 2 9 For example, the American Society for
Reproductive Medicine (formerly known as the American Fertility
Society) set forth, in its ethical standards, the view that the early embryo
"deserves respect greater than that accorded to human tissue but not the
respect accorded to actual persons.,
20
The Supreme Court of Tennessee, in a case involving the disposition of
frozen embryos, adopted the American Society for Reproductive
221Medicine's view of the definition of an early embryo. In Davis v. Davis,
the court held that the interest a divorced couple had in embryos created
by an IVF procedure prior to their divorce was not a "true property
interest," but an "ownership" interest to the extent that they had
22dispositional authority over the frozen embryos. In keeping with the
218. Kayhan Parsi, Metaphorical Imagination: The Moral and Legal Status of
Fetuses and Embryos, 2 DEPAUL J. HEALTH CARE L. 703, 754 (1999) (illustrating
the potential for the misunderstanding of the classification of embryos as
property). John Kerry, then executive director of the New York State Catholic
Conference, stated in response to the Kass decision: "I think the fundamental
problem here is that the unborn treatment of children are being treated as if they
were products, not human beings with all the attendant sanctity and dignity
attributable to human life." Id.
219. See Jennifer P. Brown, Unwanted, Anonymous, Biological Descendants:
Mandatory Donation Laws and Laws Prohibiting Preembryo Discard Violate the
Constitutional Right to Privacy, 28 U.S.F. L. REV. 183, 197-98 (1993) (reporting
that the majority of commentators support the "special respect" classification);
Jennifer Mariglioano Dehmel, To Have or Not to Have: Whose Procreative Rights
Prevail in Disputes Over Dispositions of Frozen Embryos?, 27 CONN. L. REV.
1377, 1384 (1995) (noting that a majority of commentators support the "special
respect" classification); see-also Ethical Issues, supra, note 123, at 2; Davis, 842
S.W.2d, at 596-97 (adopting the view of the American Society for Reproductive
Medicine, formerly known as The American Fertility Society, that preembryos are
neither persons nor property, but deserve "special respect").
220. Davis, 842 S.W.2d at 596 (citation omitted).
221. Davis v. Davis, 842 S.W.2d 588 (Tenn. 1992).
222. Id. at 597. Without delving into the mindset of the court, this distinction
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holdings in Del Zio, York and Kass, the court reasoned that the
disposition of frozen embryos after the divorce of a couple should begin
with the presumptively valid informed consent agreement, if one exists.'
3
Because there was no agreement between the parties regarding the
disposition of the embryos, the case was decided on the basis of
procreational autonomy. 4 In other words, the Court held that the
preferences of the progenitors should control in determining the
disposition of frozen embryos."' If their preferences cannot be
ascertained or are in dispute, the court held that the party wishing to
avoid procreation should prevail."'
As in the cases evaluating the embryo in the property context, the
Davis court decided that ultimate authority with regard to the disposition
of frozen embryos should lie with the gamete providers. Though the
court indicated that the early embryo should be accorded special respect,
it did not incorporate this sentiment into its holding. The idea of
according special respect to the early embryo helps to distinguish embryos
from mere things, and may provide a working basis for future courts that
explore the issue.
The idea of classifying the human embryo as an entity deserving special
respect is not without its critics. Dr. Edmund Pellegrino, 2" considered by
many to be the preeminent bioethicist in the United States, points out that
the ethical objections of those opposed to embryonic stem cell research
seems awfully contrarian.
223. Id.
224. See id at 604.
225. Id.
226. Id.
227. Press Release, Edmund Pellegrino, M.D., Testimony of Edmund
Pellegrino, M.D. (July 1, 1999), available at
http://www.stemcellresearch.org/testimonies/ pellegrino.htm.
Dr. Pellegrino is the John Carroll Professor of Medicine and Medical
Ethics at Georgetown University in Washington, D.C. He is also the
former director of both the Kennedy Institute of Ethics, Center for
Advanced Study of Ethics, and the Center for Clinical Bioethics at
Georgetown. Dr. Pellegrino is a Master of the American College of
Physicians, and a Fellow of the American Association for the
Advancement of Science. He has published more than 450 papers
relating to medical science, philosophy and ethics, and is a member of
numerous editorial boards.
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"cannot be over-ridden by the claim that the embryo is entitled to a
'special respect' but that this respect can be violated if there is sufficient
benefit to others." '228 Dr. Pellegrino's position that the classification of the
human embryo as an entity deserving of special respect, but not the full
rights and protections enjoyed by fully developed human beings, appears
to represent another instance of legalistic word-smithing designed to ease
the conscience of those who support the research. Perhaps he is correct.
However, as noted, the legal status of unborn and extracorporeal
embryos, at the present time, is a settled issue. It can be argued that the
term "special respect" as it is applied to the human embryo appeals to a
sense of morality, not a sense of the law. Nonetheless, the fact remains
that however the human embryo is defined with regard to its cognizable
legal rights, reasonable people will still arrive at different conclusions
regarding the morality and ethics of embryonic stem cell research.
B. Embryos as Plaintiffs
On March 8, 2001, a suit was filed in the United States District Court
for the District of Columbia to stop federal funding of embryonic stem
cell research by HHS. The suit seeks to enjoin any action by HHS or NIH
based on NIH's recently issued guidelines." 9  In Nightlight Christian
230Adoptions v. Thompson, the plaintiffs request declaratory and
injunctive relief against HHS.21 Among other things, the complaint
alleges that funding of embryonic stem cell research violates the statutory
ban enacted in 1996; threatens to financially impair plaintiffs' operations
and divert funds from adult stem cell research, greatly reduces potential
adoptive parents' chances of adopting human embryos, and that the
research itself places the lives of certain named plaintiffs ("Potential
232Embryo Adoptees") at risk and denies them legal protection.
Most relevant to this discussion is the inclusion of "Potential Embryo
228. Id.
229. See Nightlight Christian Adoptions v. Thompson, No. 01 CV 00502
(D.D.C. filed Mar. 8, 2001). A careful examination of the complaint raises serious
questions as to whether the plaintiffs have standing to assert their action. As the
case is pending during the writing of this article, it is not for this author to say
whether or not the complaint is vulnerable to a motion to dismiss. However, the
outcome here could be of great import to the debate.
230. Id.
231. Id. at 28.
232. See id. at 4-13.
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Adoptees" as "next friend of' plaintiffs in the action.233 The complaint
characterizes these plaintiffs as "persons and/or individuals under the laws
of their domiciles or otherwise and are infants or incompetents that
qualify for representation under Fed. R. Civ. P. 17(c).,, 234 "Next of friend"
plaintiff Nightlight Christian Adoption alleges that implementation of
NIH's guidelines endangers the lives of the potential embryo adoptees
and denies them the benefits of the 1996 Act, as amended.235
Whether Nightlight Christian Adoption is to be considered a proper
"next friend" of potential embryo adoptees is a matter for the federal
courts to decide. However, current authority on the issue appears to
236answer the question in the negative. In Enk v. Brophy, the Seventh
Circuit dismissed a suit brought by plaintiff Enk on behalf of two minor
children as a "next friend. '23 7 Judge Posner, writing for the court, noted
that:
[Tihe next friend must be an appropriate alter ego for a plaintiff
who is not able to litigate in his own right; that ordinarily the
eligibles will be confined to the plaintiffs parents, older siblings
(if there are no parents), or a conservator or other guardian,
akin to a trustee; that persons having only an ideological stake
in the child's case are never eligible; but that if a close relative is
unavailable and the child has no conflict-free general
representative the court may appoint a personal friend of the
plaintiff or his family, a professional who has worked with the
child, or, in desperate circumstances, a stranger whom the court
finds to be especially suitable to represent the child's interests in
the litigation.
Moreover, under Roe, the Supreme Court has made it clear that the
word "person" does not include the unborn in the context of an equal
239 240protection analysis.23  In Doe v. Shalala, the United States District
233. Id. at 4-5.
234. Id. See also FED. R. Civ. P. 17(c).
235. Omnibus Consolidated Appropriations Act of 2001, Pub. L. No. 106-554
§ 504,114 Stat. 2763 (2001).
236. 124 F.3d 893 (7th Cir. 1997).
237. Id. at 894.
238. Id. at 897 (J. Posner) (citations omitted) (emphasis added).
239. See discussion supra Section III.A.; see also Doe v. Shalala, 862 F. Supp.
1421 (D. Md. 1994), appeal dismissed, vacated, remanded sub nom. Int'l Found. for
Genetic Research v. Shalala, 57 F.3d 1066 (1995), cert. denied, 1996 U.S. LEXIS
1404 (1996).
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Court for the District of Maryland noted that not only does Federal Rule
of Civil Procedure 17(c) not apply to embryos, in or ex utero, but that
appointing a "guardian ad litem" or a "next friend 2 41 for an unspecified
number of embryos "would present the Court with an impossible task.,
242
It appears, therefore, that the "Potential Embryo Adoptees" are
improperly named as plaintiffs in the Nightlight action. The fact that
Nightlight's interests are ideologically-based, according to Judge Posner,
should preclude Nightlight from representing the interests of
cryogenically frozen embryos that could be potentially adopted. 43
Groups such as Nightlight or the Christian Medical Association are not
proper representatives of the interests of these frozen embryos. An
embryo's interests should be, and most often are, represented by its
parents.
C. Moral and Ethical Considerations
Morality is neither invented nor legislated. Rather, it is 'discovered' by
an unpacking, explication, and articulation of individual intuitions
about what ought to be undertaken and what ought not be done.2 4
Certain to be included in future court decisions regarding the
disposition of frozen embryos are the moral and ethical considerations
that accompany human embryological stem cell research. As is evident
from the range of comment on this and related subjects like fetal tissue
research and abortion, the issue is extremely contentious due to
differences among reasonable people on the moral status of the human
embryo. The schools of thought that have evolved can be broken down
roughly into two positions: (1) human embryos should not be considered
as human beings and therefore have a relative worth of protection; and
(2) human embryos enjoy the same moral status as human beings and
240. Doe v. Shalala, 862 F. Supp. 1421 (D. Md. 1994).
241. These terms are often used interchangeably. However, in the context of
a court action, generally a "guardian ad litem" is appointed to represent in the
defense of an incompetent or minor child, while a "next friend" is either
appointed or approved by the courts to assist the incompetent or minor child as a
plaintiff. See Enk, 124 F.3d at 895.
242. Shalala, 862 F. Supp. at 1426.
243. See Enk, 124 F.3d at 894.
244. Smith, supra note 2 at 119.
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245should merit equal protection.
The political machinations regarding stem cell research includes the
ban in 1996, the NBAC report in 1999, the HHS opinion, the guidelines
issued by the NIH, and the various congressional bills introduced all
evoke the underlying difference in moral perspective between pro-life
246forces and those who support federal funding of such research.
Whether or not embryonic stem cell research is a morally acceptable• .• 247
undertaking depends on one's point of view.
The pro-life movement asserts that a human being with fully cognizableS 248
legal rights is created at conception. Based on this belief, the movement
asserts that a human embryo is the moral equivalent of a child; any
249process that endangers or destroys the embryo is inherently immoral.
The Vatican's Pontifical Academy for Life's Declaration on the
Production and the Scientific and Therapeutic Use of Human Embryonic
Stem Cells (The Declaration) 0 exemplifies the pro-life position toward
245. Dr. Anne McLaren et al., Ethical Aspects of Research Involving the Use
of Human Embryos in the Context of the 5th Framework Programme, compiled in
OPINION OF THE EUROPEAN GROUP ON ETHICS IN SCIENCE AND NEW
TECHNOLOGIES TO THE EUROPEAN COMMISSION No. 12, at 5 (Nov. 23, 1998).
246. From the beginning of the debate, it has been apparent to some that the
views of those for and against embryonic stem cell research are "fundamentally
different," "extreme" and not likely to be reconciled. Id. at 1.25 (citing an
earlier report issued in 1992 by the European Commission Working Group on
Human Embryos and Research).
247. See generally Edmund D. Pellegrino, Value Neutrality, Moral Integrity,
and the Physician, 28 J.L. MED. & ETHICS 78 (2000). In his commentary, Dr.
Pellegrino rejects the notion that physicians should be morally neutral. In doing
so, he recognizes the lack of consensus with regard to issues of morality in
medicine, and asserts that ethical beliefs are not "mere preferences, changeable or
malleable in the face of practical exigencies." Id. at 79. He also recognizes the
right of autonomy in the physician with regard to his or her value-based decisions.
See id. at 79-80. This analysis should hold true when extended to everyone, not
just physicians or patients.
248. See, e.g., Leslie Bennetts, Feminists Dismayed by the Election and Unsure
of What Future Holds, N.Y. TIMES, Nov. 7, 1980, at A16 (discussing pro-life
activists' support for a constitutional amendment "that would accord to the fetus
full human and legal rights from the moment of conception")
249. See Charo, supra note 98, at 15-16.
250. POTENTIFICAL ACADEMY FOR LIFE, DECLARATION ON THE PRODUCTION
AND THE SCIENTIFIC AND THERAPEUTIC USE OF HUMAN EMBRYONIC STEM CELLS
(Aug. 25. 2000) [Hereinafter DECLARATION] available at http://www.vatican.va.
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human embryonic stem cell research.
However, before exploring the Declaration, it is imperative to discuss
briefly the basis of the opinions contained therein. The Roman Catholic
church claims that a human being with inviolate rights is created at
conception.25 This position is partially supported by adopting the
scientific "genetic model. ',Z52 In other words, because the genetic code of
the embryo is created and locked upon conception, an individual human
being with cognizable moral status is created. 23  Moreover, Roman
Catholic doctrine, as embodied in the writings of Pope John Paul II and
the Congregation for the Doctrine of the Faith, posits that techniques of
artificial reproduction are "morally unacceptable in and of themselves,
since they separate procreation from the fully human context of the
conjugal act. '' 2 4 These two teachings of the Roman Catholic church aid
the foundation of the Vatican's fierce opposition to embryonic stem cell
research.
With regard to the morality of stem cell research, the Vatican's
Declaration raises two highly relevant questions: (1) "[i]s it morally licit to
produce and/or use living human embryos for the preparation of ES
The Declaration was released as a direct response to release by the NIH of its
guidelines on human embryological stem cell research.
251. EVANGELIUM VITAE, supra note 174. See also CONGREGATION FOR THE
DOCTRINE OF THE FAITH, INSTRUCTION ON RESPECT FOR HUMAN LIFE IN ITS
ORIGIN AND ON THE DIGNITY OF PROCREATION REPLIES TO CERTAIN QUESTIONS
OF THE DAY, at 1.1. (1987) [Hereinafter INSTRUCTION]. Roman Catholic doctrine
asserts that a human being is "ensouled" at the moment of conception.
EVANGELIUM VITAE, at 60-62. This has not, however, been the position of the
Roman Catholic church since its inception. Prior to the eighteenth century, there
are historical indications that a widespread Church belief was that a fetus was not
"ensouled" until forty days after conception. See, e.g., Christopher Wolfe, Forum
on Public Morality: Public Morality and the Modern Supreme Court, 45 AM. J.
JURIS. 65, 77 n.41 (quoting Webster v. Reproductive Health Services, 492 U.S. 490,
569 (1989) (Stevens, J. dissenting)); Richard Devorkin, The Concept of
Unenumerated Rights: Unenumerated Rights: Whether and How Roe Should be
Overruled, 59 U. CHI. L. REV. 381, 403 note 36 (1992); see generally Stephen L.
Hicks, The Right to Life in Law: The Embryo and Fetus, The Body and Soul, The
Family and Society, 19 FLA. ST. U. L. REV. 805 (1992).
252. See, e.g., Kevin Wm. Wildes, The Stem Cell Report, AMERICA, Oct. 16,
1999, LEXIS.
253. Id.
254. EVANGELIUM VITAE, supra note 251, at 25; INSTRUCTION, supra note 251,
at II.B.4.a., b.
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cells?" and (2) "[i]s it morally licit to use ES cells, and the differentiated
cells obtained from them, which are supplied by other researchers or are
commercially obtainable? 2'55  The Declaration answers both of these
256questions in the negative. Concerning the usage of human embryos to
obtain stem cells for research, the Vatican alleges that "the living embryo
is... a human subject with a well defined identity" that has a "right to its
own life."25' 7 It characterizes the excision of the inner cell mass from the
blastocyte, the method for obtaining pluripotent embryonic stem cells, as
a "gravely immoral act., 258 Finally, the Roman Catholic church believes
that the human embryo, "from the first moment of its existence, must be
guaranteed that unconditional respect which is morally due to the human
being in his or her totality and unity in body and spirit."259 Thus, no end,
including the possibility that hundreds of millions of lives might be saved
or otherwise improved, justifies embryonic stem cell excision.
6°
The Vatican also condemns the use by publicly-funded scientists ofS 261
embryonic stem cells supplied by privately-funded researchers. The
Declaration argues that there is no moral distinction between using and
deriving ES stem cells, stating that using such cells "entails a proximate
material cooperation in the production and manipulation of human
embryos on the part of those producing or supplying them. 2 62 The
Vatican's position is correct: the use of stem cells excised from embryos
and the actual process of excision should not be morally or legally
distinguished.
255. DECLARATION, supra note 250, at §§ 3-4. The Declaration also raises the
question whether it is morally licit to engage in therapeutic cloning (producing
cloned human embryos to obtain ES cells). Because the NIH's guidelines
specifically bar federal funding for research utilizing therapeutic cloning
techniques, it will not be addressed in this article. STEM CELL GUIDELINES, supra
note 131, at 51,978.
256. DECLARATION, supra note 250.
257. Id. (emphasis added).




262. Id. The NIH's guidelines allow for federal funding of embryonic stem
cell research using ES cells obtained from privately-funded researchers who
derived them, but does not allow for funding of the derivation itself. STEM CELL
GUIDELINES, supra note 131, at 51, 978.
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The Vatican's position, though representative of the moral stance of
the pro-life movement on human embryonic stem cell research, does not
give a complete picture of the pro-life movement's rhetoric on the issue.
Human embryonic stem cell research has been compared to the atrocities
committed by the Nazis during World War II,"' and the syphilis
experiments conducted by the U.S. Government on African-Americans in
Tuskegee, Alabama.' 64 Stem cell experimentation has been described as
both "harvesting unborn children for profit""26 and "Frankenstein"S 266
testing. These types of comparisons closely parallel the arguments
made by the pro-life movement in its opposition to the government
funding of fetal tissue research. Unfortunately, such comparisons exhibit
a grave misunderstanding of the nature and the science of the research
itself.267
Not all religious groups, however, are morally opposed to human
embryonic stem cell research. Pope John Paul II, in his Gospel of Life,
states that "Christians, like all other people of good will, are called upon
under grave obligation of conscience not to cooperate formally in
practices which, even if permitted under civil legislation, are contrary to
God's law."26  This begs the question-what is God's law? Prominent
theologians from the four major faiths... have taken a different view."' In
263. Sharon M. Parker, Bringing the "Gospel of Life" to American
Jurisprudence: A Religious, Ethical and Philosophical Critique of Federal Funding
for Stem Cell Research, 17 J. CoNT. HEALTH L. & POL'Y 771, 807 (2000); 142
CONG. REC. S429 (daily ed. Jan. 26, 1996) (statement of Sen. Smith); Vick, supra
note 80.
264. See Vick, supra note 80.
265. EVANGELICAL PRESS NEWS SERVICE, Stem Cell Research Raises Ethical
Questions, MARANATHA CHRISTIAN J., at
http://www.mcjonline.com/news/news3011. htm (Jan. 7, 1998)
266. 141 CONG. REC. H2045 (Mar. 30, 1995) (statement of Rep. Dornan).
267. See Nikki Melina Constantine Bell, Regulating Transfer and Use of Fetal
Tissue in Transplantation Procedures: The Ethical Dimensions, 20 AM. J.L. &
MED. 277, 291, n.105 (1994) (citing John A. Robertson, Rights, Symbolism, and
Public Policy in Fetal Tissue Transplantation, 18 HASTINGS CEN. REP., at 5-6 (Dec.
1988)). The ban on federal funding for human fetal tissue research was lifted in
1993. See id. at 281.
268. EVANGELIUM VITAE, supra note 251, 74.
269. Protestantism, Catholicism, Judaism and Islam.
270. Letter from Rabbi Elliot Dorff, professor of philosophy, University of
Judaism, Margaret Farley, professor of Christian ethics, Yale University Divinity
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a 1999 letter addressed to every member of Congress, theologians voiced
their support for federal funding of human embryonic stem cell
research z.7  Position papers commissioned by the NBAC on various
religious perspectives confirm this. University of Judaism Professor Rabbi
Elliot N. Dorff, Ph.D., comments that from the Jewish perspective, excess
frozen embryos have no potential for development while outside the
womb; therefore, it is morally acceptable, perhaps even a duty, to utilize
them in research that could potentially lead to cures.n Dr. Abjulaziz
Sachedina, of the University of Virginia Department of Theological
Studies, notes that "in Islam, research on stem cells made possible by
biotechnical intervention in the early stages of life is regarded as an act of
faith of the ultimate will of God as the Giver of all life, as long as such
intervention is undertaken with the purpose of improving health.
2 73
But not surprisingly, some Roman Catholic theologians support human
stem cell research. 74 Dr. Margaret Farley, a Roman Catholic nun and
School, Nancy J. Duff, associate professor of theological ethics, Princeton
Theological Seminary, and Abdulaziz Sachedina, Department of Religious
Studies, University of Virginia, to all members of Congress (Oct. 12, 1999) (on file
with The Catholic University of America, Columbus School of Law, The Journal
of Contemporary Health Law and Policy).
271. Id. In the letter, the authors agree that all human life must be protected,
but hold that their religious beliefs also recognize "a significant difference
between an embryo suspended in liquid nitrogen that will never be implanted
inside a womb, and an unborn child who is already in the womb." Furthermore,
the authors conclude that the importance of compassion in their various faiths
compel them to support federal funding for embryonic stem cell research because
of its potential to relieve the suffering of millions. See id.
272. See NAT'L BIOETHICS ADVISORY COMM'N, ETHICAL ISSUES IN HUMAN
STEM CELL RESEARCH, VOL. III, RELIGIOUS PERSPECTIVES. [hereinafter
RELIGIOUS PERSPECTIVES] Rabbi Dorff distinguishes the view of using stem cell
research to seek out cures from using it to seek out enhancements, which would
not be approved by the Jewish faith. Volume III of the NBAC's report also
contains papers that express opposition and/or reservation about stem cell
research. The premises of those papers, however, do not differ significantly from
the position of the Vatican's Declaration and have, therefore, not been included in
this Comment. See id.
273. Id. at App. G.
274. Roman Catholic theologians who might be placed in the
"developmental" school of Catholic thought, which argues that the embryo should
not be given personal moral status until sufficient development has occurred,
include widely respected thinkers like Bernard Hiring, Karl Rahner, Joseph
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Professor of Christian Ethics at Yale University Divinity School, who is in
support of human embryonic stem cell research states that "there are
clear disagreements among Catholics on... embryo research," and that
"a case for human embryo... research can ... be made on the basis of
positions developed within the Catholic tradition., 275 Furthermore, she
argues, the case can be made without "sacrificing the [Roman Catholic]
tradition's commitments to respect human life, promote human well-
being, and honor the sacred in created realities."276 The position of the
Roman Catholic church as determined by the Vatican is that these
opinions, though offered by individuals who consider themselves Roman
Catholic, contradict the official position of the Church and are, therefore,
not representative of Roman Catholic doctrine.277
The moral controversy surrounding human embryonic stem cell
research centers on the diverse views concerning the inception of human
life. For the Vatican and pro-life groups, the dividing line between
unprotected and protected forms of human life is at the moment of
278fertilization. For others, the dividing line moves further away from
fertilization and closer toward viability of the fetus. In making its
recommendations, the National Bioethics Advisory Board took all of the
279disparate views into account. In the executive summary of its report,
the NBAC acknowledged that conscientious individuals have arrived at
different conclusions with regard to human embryonic stem cell research,
but further noted that "the development of public policy in a morally
contested area is not a novel challenge for a pluralistic democracy such as
that which exists in the United States."'2 80 The European Community's
equivalent to the NBAC, the European Group on Ethics in Science and
New Technologies, made a similar observation with regard to debate
among European countries:
Community authorities have to address.., ethical questions
Donceel, Richard McCormick, John Mahoney and Margaret Farley. Keven Win.
Wildes, The Stem Cell Report, AMERICA, Oct. 16, 1999, at 12.
275. See RELIGIOUS PERSPECTIVES, supra note 272, at App. D (testimony of
Margaret Farley, Ph.D.).
276. Id.
277. Letter from Dr. Edmund J. Pellegrino to author (Mar. 14, 2001)
[heirenafter Pellegrino letter] (on file with author).
278. Charo, supra note 98, at 16.
279. ETHICAL ISSUES, supra note 122.
280. Id.
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taking into account the moral and philosophical differences,
reflected by the extreme diversity of legal rules applicable to
human embryo research, in the 15 Member States. It is not only
legally difficult to seek harmonisation of national laws at the
Community [sic] level, but because of lack of consensus, it
would be inappropriate to impose one exclusive moral code.2 8'
This diversity of views is part of the character of a pluralistic society.
Consequently, it is equally inappropriate to impose one exclusive moral
code with regard to federal funding of embryonic stem cell research in the
United States. This, however, is precisely what conservative Roman
Catholics and opponents of embryonic stem cell research propose to do
by banning such research. A better solution, discussed infra, is a
balanced, cautious approach that takes into account all views in order to
make an informed decision as to what path to follow.
1. Philosophical quandaries
"Science cannot stop while ethics catches up... and nobody should
expect scientists to do all the thinking for the country.,2 82
It is safe to say that most people would agree with the second part of
this assertion. Whether science should stop while ethics catches up,
however, is another matter. Ethicists have issued commentary, both
subjective and objective, on the issue. However, as stated above, the
nature of the relationship between biotechnological advancement and
bioethics is best described as reactionary. While the principal ethical issue
involved in the debate over federal funding for human embryonic stem
cell research is the moral status of the embryo, other important ethical
issues remain, including whether or not government-funded researchers
who utilize embryonic stem cells, but do not destroy them, are
complicitous with those who do.
The philosophical question in this context becomes, if one feels that
destruction of frozen embryos is immoral, "What constitutes morally
wrongful cooperation with evil deeds? 283  Philosophers have focused
281. See McLaren, supra note 245, at 2.4 (emphasis added).
282. SIMPSON, supra note 26 (quoting Elvin Stackman, President of the
American Association for the Advancement of Science, Life Magazine, Jan. 9,
1950).
283. See AAAS REPORT, supra note 8, at 13.
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generally on four ways that would make someone complicitous: (1) actual,
direct involvement in the wrongful act; (2) direct encouragement of the
wrongful act; (3) indirect encouragement of the wrongful act; and (4)
without encouragement, "the appearance of endorsing, conferring
legitimacy upon, or diluting the condemnation of the wrongful act.
2 84
Human embryonic stem cell research presupposes the destruction of the
embryo from which the stem cells are extracted. Therefore, those that
believe that the use of frozen human embryos for stem cell research is
immoral must extend that belief to those who utilize the cells for research
purposes. For those who believe that the use of frozen human embryos
for stem cell research is not immoral, there is no wrongful act with which
one can be considered complicit. It is this self-evident truth that exposes
perhaps the only ethical fallacy of the NBAC's report and the guidelines
issued by NIH. In an apparent, and unsuccessful, effort to distance itself
from moral and ethical morass of providing federal funds for the
destruction of frozen human embryos for research purposes, the NBAC
recommended, and the NIH adopted, guidelines against providing federal
funding for stem cell extraction. The NBAC, thereby, succumbed to the
confusions of the popular culture and political pressures of indecisiveness.
2. Utility or futility?
The forces that are opposed to unfettered federal funding of embryonic
stem cell research have taken the position that those that support it have
adopted a utilitarian view.28' Utilitarianism is defined by Webster's New
World Dictionary as either "1. the doctrine that the worth or value of
anything is determined solely by its utility," or "2. the doctrine that the
purpose of all action should be to bring about the greatest happiness of
the greatest number." Those opposed to embryonic stem cell research
would argue that the worth of the human embryo should not be
determined solely by its utility, and they are correct. However, the
limitations that the moniker of this definition of "utilitarianism" impose
generally belie the morality and ethos of an approach that supports
federal funding for embryonic research. 28 The second definition, where
284. Id. at 14.
285. See, e.g., Pellegrino letter, supra note 277.
286. WEBSTER'S NEW WORLD DICTIONARY 1605 (College Ed. 1968).
287. In fact, philosopher David Hume sees the concept of utility as a central
precept of morality. In his work Moral and Political Philosophy, Hume states:
It appears to be a matter of fact that the circumstance of utility, in all
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the utility of stem cell research, and not the utility of the embryo is the
focal point, is more appropriate in an ethical and moral evaluation.
For example, recently, eighty Nobel Laureates sent a letter advocating
federal funding for embryonic research to President George W. Bush.2
In the letter, the Nobel Laureates, unquestionably some of the most
brilliant minds in all fields of science and humanity, recognize the ethical
dilemma raised by such research:
While we recognize the legitimate ethical issues raised by this
research, it is important to understand that the cells being used
in this research were destined to be discarded in any case. Under
these circumstances, it would be tragic to waste this opportunity
to pursue the work that could potentially alleviate human
suffering. For the past 35 years many of the common human
virus vaccines-such as measles, rubella, hepatitis A, rabies and
poliovirus-have been produced in cells derived from a human
fetus to the benefit of tens of millions of Americans. Thus
precedent has been established for the use of fetal tissue that
would otherwise be discarded.289
Richard Doerflinger's (of the National Conference of Catholic
Bishops) response to the Nobel Laureates "utilitarian" approach was to
say "[n]obody ever said these Nobel prizes are for ethics. ' '290 This tacit
implication that the various Nobelists who authored and signed the letter,
along with the scores of others who support federal funding of embryonic
stem cell research, lack the proper ethical foundation is indicative of the
moral absolutism of those opposed to it. Mr. Doerflinger, along with
subjects, is a source of praise and approbation; that it is constantly
appealed to in all moral decisions concerning the merit and demerit of
actions; that it is the sole source of that high regard paid to justice,
fidelity, honour, allegiance, and chastity; that it is inseparable from all
other social virtues, humanity, generosity, charity, affability, lenity,
mercy, and moderation; and, in a word, that is a foundation of the chief
part of morals, which has a reference to mankind and our fellow
creatures.
DAVID HUME, MORAL AND POL. PHIL. 221 (1741)(Henry D. Aiken ed., Hafner
Press 1948) (emphasis in original).
288. Letter from Eighty Nobel Laureates to George W. Bush, President of the
United States (Feb. 21, 2001), available at http://www.washingtonpost.com.
289. Id.
290. Rick Weiss, Nobel Laureates Back Stem Cell Research, WASH. POST, Feb.
22, 2001, at A2.
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many of the groups aligned with him against the research, fails to see that
their conception of morality and ethics is not altogether pervasive. The
objective in determining ethically sound policy is to weigh the opinions of
all, investigate and understand the facts, and make an informed decision.
The NIH, bolstered by the opinion set forth by the leadership of the HHS
under the Clinton Administration, did just that. It would be futile to
attempt to convince the moral absolutist, who is opposed to embryonic
stem cell research, that the path chosen is both morally and ethically
acceptable. However, this futility should not be misunderstood to
translate into a barrier of defiance among common Americans.
CONCLUSIONS AND RECOMMENDATIONS
R. Alta Charo, an NBAC Commissioner, has noted that the "search for
a definitive, intrinsic moral status of the embryo is as doomed as the
hunting of [Lewis Carroll's] illusive snark. 291 She sees this as the fallacy
that embodied the Clinton Administration's approach to providing
federal funds for embryonic stem cell research . 2  In distinguishing
between the derivation and use of stem cells from extraneous
cryogenically frozen embryos, the former administration set up its
interpretation of the 1996 Act to well-founded criticism that it lacks a
moral and ethical foundation. Professor Charo aptly states that the panel
would have been served better by "[c]andidly acknowledging that embryo
research will violate a cherished ideal of millions-that all human life is
inviolate-but arguing that its beneficiaries have a claim to its life-
promoting potential for [medical] advances."'2 93
This observation still holds true. In a pluralistic society, it is inevitable
that when a direction is taken on a public policy issue so hotly contested,
as this, the philosophical chasm that separates it is magnified, perhaps
artificially so. Though pro-life forces have been the most adamant and
outspoken opponents of human embryonic stem cell research, some of
their constituents, as they have become more familiar with the enormous
healing potential that this research promises, have begun to break ranks
291. Charo, supra note 98 (citing LEWIS CARROLL, THE HUNTING OF THE
ILLUSIVE SNARK 1 (Chatto & Windus Ltd., 1993) (1876). In Carroll's book, "an
ill-fated crew of snark-hunters... set forth to search for a beast whom they could
neither recognize nor find.")
292. See Charo, supra note 98.
293. Id. at 27.
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and support federal funding of this research. This phenomenon and the
reasons behind it are captured in a statement in support for embryonic
stem cell research by Dr. Arturo Brito, a pediatrician at the University of
Miami School of Medicine, who is, incidentally, a Roman Catholic:
We [the NBAC] were really very careful. We were writing this
[the NBAC report] for the American people. Even though I am
uncomfortable with abortions, I am comfortable about using
embryos that are going to be discarded from IVF (in vitro
fertilization), because they've been tossed out for years or
decades. If they can be put to use to save lives, then they should
be.
2 9 4
Legalistic approaches and exaggerated appeals to the moral "high
ground" on an issue that has no moral high ground simply exposes the
path chosen to misunderstanding, confusion and anger. The Bush
Administration ought not only to continue the good work of the NBAC
and the NIH, but should also seriously consider extending federal funding
to the derivation of stem cells. The moral distinction between deriving
stem cells from frozen embryos and using them only for research purposes
is specious at best, since experimentation with regard to stem cells
necessarily implicates derivation. Moreover, adamant opponents of stem
cell research perhaps ought to take a step back from such morally
absolutist views, and lend a bit more credibility to the position held by
millions of other Americans. These supporters either suffer from or have
a family member who suffers from a degenerative condition that could
ultimately be treated with the fruits of this research. They, like
approximately 65% of all Americans,29 support federal funding for stem
cell research because they believe the potential medical benefits outweigh
carefully considered moral and legal conundrums.
While it is true that absolutism can be attributed to either side in this
conflict, it is erroneous to claim that there exist only two views with
regard to the morality and ethics of embryonic stem cell research. The
294. McVicar, supra note 161.
295. JUVENILE DIABETES RESEARCH FOUNDATION, JUVENILE DIABETES
RESEARCH FOUNDATION INTERNATIONAL STATEMENT ON PRESIDENT BUSH'S
REMARKS ABOUT FEDERAL FUNDING OF STEM CELL RESEARCH, PR NEWSWIRE,
Jan. 26, 2001, LEXIS, Nexis Library, ALLNEWS file (referring to a poll
conducted between January 12 and January 15, 2001 which shows that sixty-five
percent of Americans surveyed said they support federal funding for stem cell
research)(on file with author).
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truth is that there are a myriad of differences in interpretations of the
ethical and moral implications set forth with regard to this research.
Those differences should be taken into account and carefully weighed as
we, as a society, move forward. The best way to ensure that is through
full federal funding, which will not only promote the research to its
scientific fruition, but will provide also for public oversight in an area that
desperately requires it. President Bush's policy falls far short of this
desirable aim. Despite the ferocity of the debate, legally, morally and
ethically, federal funding for stem cell research is well supported, and is
the right path to a healthier civilization.
